| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase binding | 5.24e-09 | 16 | 191 | 6 | GO:0008179 | |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 8.49e-06 | 5 | 191 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | calcium ion binding | CLSTN3 MYL1 DGKG TENM2 FAT1 FAT4 CALM1 CALM2 CALM3 PCDHGA11 PCDHGA7 ANXA7 CDH19 THBS1 CELSR3 CELSR2 HMCN1 TLL2 ANXA10 CDH4 NIN | 1.07e-05 | 749 | 191 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 1.69e-05 | 6 | 191 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 STARD8 RCC1 DENND2B RGPD5 DOCK1 RANBP2 RGPD8 RAPGEF4 DOCK10 ARHGEF12 SIPA1 EEF1D SIPA1L1 RACGAP1 RPGR | 3.13e-05 | 507 | 191 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 STARD8 RCC1 DENND2B RGPD5 DOCK1 RANBP2 RGPD8 RAPGEF4 DOCK10 ARHGEF12 SIPA1 EEF1D SIPA1L1 RACGAP1 RPGR | 3.13e-05 | 507 | 191 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 6.94e-05 | 9 | 191 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 9.84e-05 | 10 | 191 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.27e-04 | 81 | 191 | 6 | GO:0035254 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.41e-04 | 118 | 191 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 2.30e-04 | 13 | 191 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | soluble NSF attachment protein activity | 2.71e-04 | 3 | 191 | 2 | GO:0005483 | |
| GeneOntologyMolecularFunction | titin binding | 2.90e-04 | 14 | 191 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP32 STARD8 RGPD5 DOCK1 RANBP2 RGPD8 ARHGEF12 SIPA1 SIPA1L1 RACGAP1 | 3.68e-04 | 279 | 191 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 4.40e-04 | 16 | 191 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 4.40e-04 | 16 | 191 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | ARHGAP32 CLSTN3 STARD8 PSMD1 RCC1 DENND2B RGPD5 DOCK1 RANBP2 FLT3 RGPD8 CALM1 CALM2 HTRA2 CALM3 RAPGEF4 DOCK10 ARHGEF12 SIPA1 NLRP2 EEF1D THBS1 SIPA1L1 RACGAP1 AKAP11 RPGR PPP1R16A | 4.69e-04 | 1418 | 191 | 27 | GO:0030234 |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 5.31e-04 | 17 | 191 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.56e-04 | 70 | 191 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 6.23e-04 | 41 | 191 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 6.32e-04 | 18 | 191 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | toxic substance binding | 6.32e-04 | 18 | 191 | 3 | GO:0015643 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 7.48e-04 | 43 | 191 | 4 | GO:0043548 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 8.71e-04 | 20 | 191 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | serine-type carboxypeptidase activity | 8.93e-04 | 5 | 191 | 2 | GO:0004185 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 9.67e-04 | 46 | 191 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 1.14e-03 | 48 | 191 | 4 | GO:0008200 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 1.16e-03 | 22 | 191 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 1.16e-03 | 22 | 191 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 1.32e-03 | 50 | 191 | 4 | GO:0016248 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.36e-03 | 172 | 191 | 7 | GO:0044325 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 1.43e-03 | 51 | 191 | 4 | GO:0141110 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.67e-03 | 229 | 191 | 8 | GO:0140993 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.76e-03 | 231 | 191 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CLSTN3 XIRP1 KIF1A MARK3 KIF9 VILL STARD9 MYO3B MYPN DLG4 CALM1 CALM2 CALM3 KIF16B DYRK1A PPP5C SIPA1L1 RACGAP1 PALLD MYO16 NIN | 1.98e-03 | 1099 | 191 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | protein kinase A binding | 2.30e-03 | 58 | 191 | 4 | GO:0051018 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 2.52e-03 | 98 | 191 | 5 | GO:0048306 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.75e-03 | 100 | 191 | 5 | GO:0030594 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 ARHGAP32 CLSTN3 KIF1A TENM2 CHRNA7 PTPRO NEGR1 PTPRS MYPN VPS13A TRPV2 DLG4 CHRFAM7A SLC23A2 NEDD4L ARX DOCK10 RUNX3 BTBD3 TMEM106B CELSR3 CELSR2 SIPA1L1 CDH4 PALLD MYO16 NIN | 1.05e-09 | 802 | 188 | 28 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 ARHGAP32 CLSTN3 KIF1A TENM2 CHRNA7 PTPRO NEGR1 PTPRS MYPN VPS13A TRPV2 DLG4 CHRFAM7A SLC23A2 NEDD4L ARX DOCK10 RUNX3 BTBD3 TMEM106B CELSR3 CELSR2 SIPA1L1 CDH4 PALLD MYO16 NIN | 1.67e-09 | 819 | 188 | 28 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 ARHGAP32 CLSTN3 KIF1A TENM2 CHRNA7 PTPRO NEGR1 PTPRS MYPN VPS13A TRPV2 DLG4 CHRFAM7A SLC23A2 NEDD4L ARX DOCK10 RUNX3 BTBD3 TMEM106B CELSR3 CELSR2 SIPA1L1 CDH4 PALLD MYO16 NIN | 2.01e-09 | 826 | 188 | 28 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 ARHGAP32 CLSTN3 KIF1A TENM2 CHRNA7 FAT1 PTPRO NEGR1 PTPRS MYO3B MYPN VPS13A TRPV2 DLG4 CHRFAM7A SLC23A2 NEDD4L ANXA7 ARX DOCK10 SIPA1 RUNX3 CDH19 BTBD3 TMEM106B CELSR3 CELSR2 SIPA1L1 CDH4 PALLD MYO16 NIN | 1.02e-08 | 1194 | 188 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 ARHGAP32 KIF1A TENM2 CHRNA7 PTPRO PTPRS MYO3B MYPN TRPV2 DLG4 CHRFAM7A NEDD4L ARX DOCK10 RUNX3 BTBD3 TMEM106B CELSR3 CELSR2 SIPA1L1 CDH4 PALLD NIN | 8.96e-08 | 748 | 188 | 24 | GO:0048667 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CLSTN3 FAT1 MYPN FAT4 PCDHGA11 PCDHGA7 CDH19 CELSR3 CELSR2 HMCN1 CDH4 PALLD | 1.54e-07 | 187 | 188 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 ARHGAP32 CLSTN3 KIF1A DGKG TENM2 CHRNA7 PTPRO NEGR1 PTPRS MYO3B MYPN VPS13A TRPV2 DLG4 CHRFAM7A SLC23A2 FAT4 NEDD4L ARX RAPGEF4 DOCK10 RUNX3 BTBD3 TMEM106B CELSR3 CELSR2 SIPA1L1 CDH4 PALLD MYO16 NIN | 1.95e-07 | 1285 | 188 | 32 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CLSTN3 TENM2 FAT1 PTPRS MYPN FAT4 PCDHGA11 PCDHGA7 CDH19 CLDN1 CELSR3 CELSR2 HMCN1 CDH4 PALLD | 1.97e-07 | 313 | 188 | 15 | GO:0098742 |
| GeneOntologyBiologicalProcess | neuron development | TANC2 ARHGAP32 CLSTN3 KIF1A DGKG TENM2 CHRNA7 PTPRO NEGR1 PTPRS MYO3B MYPN VPS13A TRPV2 DLG4 CHRFAM7A SLC23A2 FAT4 NEDD4L HTRA2 ARX RAPGEF4 DOCK10 RUNX3 BTBD3 TMEM106B CELSR3 CELSR2 SIPA1L1 RPGR CDH4 PALLD MYO16 NIN | 3.85e-07 | 1463 | 188 | 34 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 7.45e-07 | 3 | 188 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 8.13e-07 | 9 | 188 | 4 | GO:0060316 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | TANC2 KIF1A CHRNA7 DLG4 CHRFAM7A NEDD4L DOCK10 BTBD3 TMEM106B CELSR2 SIPA1L1 | 2.13e-06 | 198 | 188 | 11 | GO:0048813 |
| GeneOntologyBiologicalProcess | action potential | CHRNA7 KCND3 CHRFAM7A AKAP6 NEDD4L CALM1 CALM2 CALM3 RAPGEF4 GRIN2A ATP1A2 | 2.46e-06 | 201 | 188 | 11 | GO:0001508 |
| GeneOntologyBiologicalProcess | dendrite development | TANC2 KIF1A DGKG CHRNA7 PTPRS DLG4 CHRFAM7A NEDD4L RAPGEF4 DOCK10 BTBD3 TMEM106B CELSR2 SIPA1L1 | 2.57e-06 | 335 | 188 | 14 | GO:0016358 |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 7.35e-06 | 5 | 188 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 1.06e-05 | 115 | 188 | 8 | GO:0097061 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.15e-05 | 33 | 188 | 5 | GO:0010880 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 1.46e-05 | 6 | 188 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 1.46e-05 | 6 | 188 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 2.05e-05 | 37 | 188 | 5 | GO:0014808 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 2.18e-05 | 127 | 188 | 8 | GO:0106027 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.33e-05 | 167 | 188 | 9 | GO:0060048 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 2.67e-05 | 39 | 188 | 5 | GO:1903514 | |
| GeneOntologyBiologicalProcess | developmental growth | ARHGAP32 CLSTN3 XIRP1 UBTFL6 KMT2C PTPRS VPS13A TRPV2 SLC23A2 KDM6A AKAP6 FLT3 NEDD4L HTRA2 ARX DYRK1A SIK3 THBS1 TLL2 ANKRD11 CDH4 NIN | 3.07e-05 | 911 | 188 | 22 | GO:0048589 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | NEGR1 ACKR2 CAMTA1 AKAP6 CALM1 CALM2 CALM3 DYRK1A GRIN2A GRM1 ATP1A2 | 3.45e-05 | 266 | 188 | 11 | GO:0019722 |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 4.04e-05 | 8 | 188 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by baroreceptor feedback | 4.04e-05 | 8 | 188 | 3 | GO:0003025 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 4.30e-05 | 22 | 188 | 4 | GO:0010881 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 4.85e-05 | 44 | 188 | 5 | GO:0070296 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | TANC2 CLSTN3 KIF1A CHRNA7 PTPRO NEGR1 PTPRS DLG4 CHRFAM7A DOCK1 RAPGEF4 DOCK10 SIPA1L1 | 5.84e-05 | 387 | 188 | 13 | GO:0050807 |
| GeneOntologyBiologicalProcess | nervous system process involved in regulation of systemic arterial blood pressure | 6.16e-05 | 24 | 188 | 4 | GO:0001976 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | TANC2 CLSTN3 KIF1A CHRNA7 PTPRO NEGR1 PTPRS DLG4 CHRFAM7A DOCK1 RAPGEF4 DOCK10 SIPA1L1 | 7.18e-05 | 395 | 188 | 13 | GO:0050803 |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 8.26e-05 | 2 | 188 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 8.54e-05 | 26 | 188 | 4 | GO:0060314 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 8.54e-05 | 26 | 188 | 4 | GO:0086064 | |
| GeneOntologyBiologicalProcess | heart contraction | MYL1 CHRNA7 KCND3 CHRFAM7A AKAP6 NEDD4L CALM1 CALM2 CALM3 ACE2 ATP1A2 | 9.56e-05 | 298 | 188 | 11 | GO:0060047 |
| GeneOntologyBiologicalProcess | head development | SPHK2 KIF1A NAPA NEGR1 PTPRS NAV2 COL2A1 FAT4 CALM1 CALM2 HTRA2 CALM3 ARX GRIN2A BTBD3 CELSR2 SMARCA1 ANKRD11 ATP1A2 MYO16 NIN | 1.03e-04 | 919 | 188 | 21 | GO:0060322 |
| GeneOntologyBiologicalProcess | organelle assembly | XIRP1 INCENP CENPC RCC1 HAUS3 DDB1 KIF9 PIK3C3 NEGR1 PTPRS STARD9 PRRC2C MYPN WNK3 KNL1 CELSR3 CELSR2 SIPA1L1 DNAH17 PRKAA2 RACGAP1 RPGR LRBA CFAP46 | 1.11e-04 | 1138 | 188 | 24 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 1.15e-04 | 28 | 188 | 4 | GO:0010882 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.17e-04 | 11 | 188 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | XIRP1 INCENP CENPC RCC1 HAUS3 DDB1 KIF9 NEGR1 STARD9 PRRC2C MYPN WNK3 PRKAA2 RACGAP1 | 1.22e-04 | 475 | 188 | 14 | GO:0140694 |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | CLSTN3 NEGR1 PTPRS DLG4 DOCK1 NEDD4L DOCK10 CLDN1 ACE2 THBS1 SIPA1L1 | 1.32e-04 | 309 | 188 | 11 | GO:1901888 |
| GeneOntologyBiologicalProcess | heart process | MYL1 CHRNA7 KCND3 CHRFAM7A AKAP6 NEDD4L CALM1 CALM2 CALM3 ACE2 ATP1A2 | 1.32e-04 | 309 | 188 | 11 | GO:0003015 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.45e-04 | 87 | 188 | 6 | GO:0086001 | |
| GeneOntologyBiologicalProcess | postsynapse organization | TANC2 KIF1A CHRNA7 PTPRS DLG4 CHRFAM7A DOCK1 RAPGEF4 DOCK10 GRIN2A SIPA1L1 | 1.47e-04 | 313 | 188 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | growth | ARHGAP32 SPHK2 CLSTN3 XIRP1 UBTFL6 KMT2C PTPRS VPS13A TRPV2 SLC23A2 KDM6A MNDA AKAP6 FLT3 NEDD4L HTRA2 ARX DYRK1A SIK3 SIPA1 THBS1 TLL2 ANKRD11 CDH4 NIN | 1.51e-04 | 1235 | 188 | 25 | GO:0040007 |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 1.54e-04 | 12 | 188 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 1.54e-04 | 12 | 188 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | positive regulation of cation channel activity | 1.56e-04 | 56 | 188 | 5 | GO:2001259 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 1.64e-04 | 89 | 188 | 6 | GO:0055117 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane transporter activity | 1.72e-04 | 266 | 188 | 10 | GO:0022898 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.75e-04 | 217 | 188 | 9 | GO:0006941 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRR1 XIRP1 CHRNA7 KCND3 DLG4 CHRFAM7A AKAP6 NEDD4L CALM1 CALM2 CALM3 RAPGEF4 GRIN2A GRM1 ATP1A2 | 1.96e-04 | 559 | 188 | 15 | GO:0042391 |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 1.97e-04 | 32 | 188 | 4 | GO:0010800 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 1.99e-04 | 13 | 188 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 CLSTN3 KIF1A CHRNA7 PTPRO NEGR1 PTPRS DLG4 CHRFAM7A DOCK1 NEDD4L RAPGEF4 DOCK10 GRIN2A CDH19 CLDN1 ACE2 THBS1 SIPA1L1 CDH4 PALLD | 2.28e-04 | 974 | 188 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 2.46e-04 | 3 | 188 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | SNARE complex disassembly | 2.46e-04 | 3 | 188 | 2 | GO:0035494 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 2.53e-04 | 228 | 188 | 9 | GO:0046777 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 2.63e-04 | 97 | 188 | 6 | GO:0032414 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 2.81e-04 | 35 | 188 | 4 | GO:0010644 | |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 2.94e-04 | 99 | 188 | 6 | GO:0032465 | |
| GeneOntologyBiologicalProcess | blood circulation | MYL1 CHRNA7 KCND3 PTPRO NAV2 CHRFAM7A SLC23A2 AKAP6 NEDD4L CALM1 CALM2 CALM3 ARHGEF12 ACE2 SCPEP1 ATP1A2 | 3.05e-04 | 648 | 188 | 16 | GO:0008015 |
| GeneOntologyBiologicalProcess | cardiac conduction | 3.10e-04 | 100 | 188 | 6 | GO:0061337 | |
| GeneOntologyBiologicalProcess | brain development | SPHK2 KIF1A NAPA NEGR1 PTPRS NAV2 FAT4 CALM1 CALM2 HTRA2 CALM3 ARX GRIN2A BTBD3 CELSR2 SMARCA1 ATP1A2 MYO16 NIN | 3.35e-04 | 859 | 188 | 19 | GO:0007420 |
| GeneOntologyBiologicalProcess | regulation of blood pressure | CHRNA7 PTPRO NAV2 CHRFAM7A NEDD4L ARHGEF12 ACE2 SCPEP1 ATP1A2 | 3.37e-04 | 237 | 188 | 9 | GO:0008217 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CLSTN3 TENM2 FAT1 NEGR1 PTPRS MYPN DLG4 FAT4 COL13A1 PCDHGA11 PCDHGA7 FNDC3A RUNX3 CDH19 CLDN1 THBS1 CELSR3 CELSR2 HMCN1 ASS1 CDH4 PALLD | 3.41e-04 | 1077 | 188 | 22 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of amide metabolic process | 3.49e-04 | 37 | 188 | 4 | GO:0034250 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 3.82e-04 | 16 | 188 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid metabolic process | 3.82e-04 | 16 | 188 | 3 | GO:0019852 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 3.87e-04 | 38 | 188 | 4 | GO:0140058 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 4.28e-04 | 39 | 188 | 4 | GO:1901021 | |
| GeneOntologyBiologicalProcess | regulation of transporter activity | 4.35e-04 | 299 | 188 | 10 | GO:0032409 | |
| GeneOntologyBiologicalProcess | response to metal ion | DLG4 CALM1 CALM2 CALM3 ANXA7 GRIN2A CLDN1 THBS1 PPP5C PRKAA2 ASS1 ATP1A2 | 4.44e-04 | 415 | 188 | 12 | GO:0010038 |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 4.46e-04 | 107 | 188 | 6 | GO:0032411 | |
| GeneOntologyBiologicalProcess | developmental cell growth | ARHGAP32 CLSTN3 PTPRS TRPV2 SLC23A2 AKAP6 NEDD4L DYRK1A CDH4 NIN | 4.59e-04 | 301 | 188 | 10 | GO:0048588 |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 4.61e-04 | 17 | 188 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 4.82e-04 | 249 | 188 | 9 | GO:0008016 | |
| GeneOntologyBiologicalProcess | generation of ovulation cycle rhythm | 4.90e-04 | 4 | 188 | 2 | GO:0060112 | |
| GeneOntologyBiologicalProcess | choline catabolic process | 4.90e-04 | 4 | 188 | 2 | GO:0042426 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | ARHGAP32 PTPRS TRPV2 SLC23A2 AKAP6 FLT3 NEDD4L HTRA2 ARX DYRK1A TLL2 CDH4 | 5.04e-04 | 421 | 188 | 12 | GO:0048638 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TANC2 ARHGAP32 KIF1A DGKG PTPRO NEGR1 PTPRS TRPV2 DLG4 NEDD4L RAPGEF4 TMEM106B SIPA1L1 CDH4 NIN | 5.08e-04 | 612 | 188 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transporter activity | 5.20e-04 | 41 | 188 | 4 | GO:1901020 | |
| GeneOntologyBiologicalProcess | cellular response to interferon-beta | 5.20e-04 | 41 | 188 | 4 | GO:0035458 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transport | 5.38e-04 | 154 | 188 | 7 | GO:0051928 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 5.43e-04 | 111 | 188 | 6 | GO:0006942 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 5.50e-04 | 18 | 188 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 5.89e-04 | 256 | 188 | 9 | GO:0032412 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 6.25e-04 | 43 | 188 | 4 | GO:2000463 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 6.48e-04 | 19 | 188 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | lactone metabolic process | 6.48e-04 | 19 | 188 | 3 | GO:1901334 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine phosphorylation | 6.55e-04 | 115 | 188 | 6 | GO:0018107 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF1A INCENP RCC1 HAUS3 DDB1 CHRNA7 KIF9 STARD9 VPS13A GAPDHS CHRFAM7A KIF16B DYRK1A SIK3 CELSR2 DNAH17 PRKAA2 RACGAP1 RPGR CFAP46 NIN | 6.77e-04 | 1058 | 188 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | cell junction assembly | CLSTN3 PTPRO NEGR1 PTPRS DLG4 DOCK1 NEDD4L DOCK10 CDH19 CLDN1 ACE2 THBS1 SIPA1L1 CDH4 | 7.52e-04 | 569 | 188 | 14 | GO:0034329 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 7.58e-04 | 20 | 188 | 3 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of protein kinase C signaling | 7.58e-04 | 20 | 188 | 3 | GO:0090036 | |
| GeneOntologyBiologicalProcess | sensory processing | 8.12e-04 | 5 | 188 | 2 | GO:0050893 | |
| GeneOntologyBiologicalProcess | negative regulation of protein kinase C signaling | 8.12e-04 | 5 | 188 | 2 | GO:0090038 | |
| GeneOntologyBiologicalProcess | meiotic metaphase I homologous chromosome alignment | 8.12e-04 | 5 | 188 | 2 | GO:0043060 | |
| GeneOntologyBiologicalProcess | regulation of calcium-mediated signaling | 8.55e-04 | 121 | 188 | 6 | GO:0050848 | |
| GeneOntologyCellularComponent | dendritic spine | TANC2 ARHGAP32 TENM2 CHRNA7 KCND3 PTPRO DLG4 CHRFAM7A RAPGEF4 DOCK10 GRIN2A GRM1 SIPA1L1 ATP1A2 | 6.39e-08 | 242 | 194 | 14 | GO:0043197 |
| GeneOntologyCellularComponent | neuron spine | TANC2 ARHGAP32 TENM2 CHRNA7 KCND3 PTPRO DLG4 CHRFAM7A RAPGEF4 DOCK10 GRIN2A GRM1 SIPA1L1 ATP1A2 | 8.24e-08 | 247 | 194 | 14 | GO:0044309 |
| GeneOntologyCellularComponent | postsynapse | TANC2 GABRR1 ARHGAP32 CLSTN3 KIF1A NAPA TENM2 CHRNA7 HNRNPH1 HNRNPH2 KCND3 PTPRO PIK3C3 PTPRS DLG4 CHRFAM7A DOCK1 COL13A1 RAPGEF4 DOCK10 GRIN2A GRM1 CELSR3 NAPB SIPA1L1 ATP1A2 | 2.83e-06 | 1018 | 194 | 26 | GO:0098794 |
| GeneOntologyCellularComponent | growth cone | TENM2 CHRNA7 PTPRO PTPRS TRPV2 CHRFAM7A CALM1 CALM2 CALM3 RAPGEF4 PALLD NIN | 3.28e-06 | 245 | 194 | 12 | GO:0030426 |
| GeneOntologyCellularComponent | site of polarized growth | TENM2 CHRNA7 PTPRO PTPRS TRPV2 CHRFAM7A CALM1 CALM2 CALM3 RAPGEF4 PALLD NIN | 4.56e-06 | 253 | 194 | 12 | GO:0030427 |
| GeneOntologyCellularComponent | dendrite | TANC2 ARHGAP32 CLSTN3 KIF1A MARK3 TENM2 CHRNA7 KCND3 PTPRO NEGR1 DLG4 CHRFAM7A RAPGEF4 DYRK1A DOCK10 GRIN2A GRM1 PPP5C SIPA1L1 PRKAA2 ATP1A2 NIN | 1.65e-05 | 858 | 194 | 22 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 ARHGAP32 CLSTN3 KIF1A MARK3 TENM2 CHRNA7 KCND3 PTPRO NEGR1 DLG4 CHRFAM7A RAPGEF4 DYRK1A DOCK10 GRIN2A GRM1 PPP5C SIPA1L1 PRKAA2 ATP1A2 NIN | 1.71e-05 | 860 | 194 | 22 | GO:0097447 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | CLSTN3 CHRNA7 KCND3 PTPRO PTPRS DLG4 CHRFAM7A GRIN2A GRM1 CELSR3 | 1.92e-05 | 201 | 194 | 10 | GO:0099634 |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 ARHGAP32 CLSTN3 CHRNA7 HNRNPH1 HNRNPH2 KCND3 PTPRO PTPRS DLG4 CHRFAM7A RAPGEF4 GRIN2A GRM1 CELSR3 SIPA1L1 | 1.99e-05 | 503 | 194 | 16 | GO:0099572 |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 ARHGAP32 CLSTN3 CHRNA7 HNRNPH1 HNRNPH2 PTPRO PTPRS DLG4 CHRFAM7A RAPGEF4 GRIN2A GRM1 CELSR3 SIPA1L1 | 4.15e-05 | 477 | 194 | 15 | GO:0032279 |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 ARHGAP32 CLSTN3 KIF1A MARK3 TENM2 CHRNA7 KCND3 PTPRO NEGR1 PTPRS VPS13A DLG4 CHRFAM7A RAPGEF4 DYRK1A DOCK10 GRIN2A GRM1 PPP5C SIPA1L1 PRKAA2 ASS1 ATP1A2 PALLD NIN | 7.23e-05 | 1228 | 194 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | axon | TANC2 KIF1A TENM2 CHRNA7 PTPRO PTPRS MYPN TRPV2 DLG4 CHRFAM7A CALM1 CALM2 CALM3 RAPGEF4 DYRK1A GRIN2A GRM1 PRKAA2 IL1R1 PALLD NIN | 8.69e-05 | 891 | 194 | 21 | GO:0030424 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRR1 CLSTN3 TENM2 CHRNA7 KCND3 PTPRO PTPRS DLG4 CHRFAM7A COL13A1 GRIN2A GRM1 CELSR3 | 1.11e-04 | 405 | 194 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 ARHGAP32 CLSTN3 CHRNA7 HNRNPH1 HNRNPH2 PTPRO PTPRS DLG4 CHRFAM7A RAPGEF4 GRIN2A GRM1 CELSR3 SIPA1L1 | 1.16e-04 | 523 | 194 | 15 | GO:0098984 |
| GeneOntologyCellularComponent | sperm flagellum | 1.81e-04 | 214 | 194 | 9 | GO:0036126 | |
| GeneOntologyCellularComponent | distal axon | TENM2 CHRNA7 PTPRO PTPRS TRPV2 CHRFAM7A CALM1 CALM2 CALM3 RAPGEF4 GRIN2A PALLD NIN | 2.24e-04 | 435 | 194 | 13 | GO:0150034 |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 GABRR1 CLSTN3 NAPA TENM2 PTPRO PIK3C3 PTPRS DLG4 DOCK1 NEDD4L RAPGEF4 DOCK10 GRIN2A GRM1 EEF1D CELSR3 NAPB SIPA1L1 | 2.27e-04 | 817 | 194 | 19 | GO:0098978 |
| GeneOntologyCellularComponent | spine apparatus membrane | 2.55e-04 | 3 | 194 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 ARHGAP32 CLSTN3 HNRNPH1 HNRNPH2 PTPRO PTPRS DLG4 RAPGEF4 GRIN2A GRM1 CELSR3 SIPA1L1 | 3.17e-04 | 451 | 194 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | synaptic membrane | GABRR1 CLSTN3 NAPA TENM2 CHRNA7 KCND3 PTPRO PTPRS DLG4 CHRFAM7A COL13A1 GRIN2A GRM1 CELSR3 NAPB | 3.72e-04 | 583 | 194 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 3.97e-04 | 238 | 194 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 6.72e-04 | 157 | 194 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | synaptobrevin 2-SNAP-25-syntaxin-1a complex | 8.41e-04 | 5 | 194 | 2 | GO:0070044 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 8.41e-04 | 5 | 194 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.17e-03 | 277 | 194 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | microtubule | KIF1A INCENP HAUS3 KIF9 CALM1 CALM2 CALM3 KIF16B DYRK1A DPP9 DNAH17 RACGAP1 NIN | 1.48e-03 | 533 | 194 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 1.59e-03 | 91 | 194 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.31e-03 | 8 | 194 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | potassium channel complex | 2.86e-03 | 104 | 194 | 5 | GO:0034705 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRR1 CHRNA7 KCND3 DLG4 CHRFAM7A AKAP6 CALM1 CALM2 CALM3 GRIN2A | 2.89e-03 | 378 | 194 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | spine apparatus | 2.96e-03 | 9 | 194 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | sperm midpiece | 2.96e-03 | 64 | 194 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 3.20e-03 | 32 | 194 | 3 | GO:0005721 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.67e-03 | 10 | 194 | 2 | GO:0044614 | |
| MousePheno | hypoactivity | KIF1A CHRNA7 HNRNPH2 KCND3 NEGR1 VPS13A ANKRD28 DLG4 ATP13A3 CHRFAM7A BICC1 NEDD4L HTRA2 ARX DYRK1A ARHGEF12 FNDC3A GRIN2A GRM1 HIF1AN BTBD3 EEF1D FAM193A NAPB LMO1 AKAP11 ATP1A2 IL1R1 CDH4 | 3.05e-06 | 1023 | 157 | 29 | MP:0031392 |
| MousePheno | seizures | ARHGAP32 CHRNA7 HNRNPH2 PTPRO MYO3B CHRFAM7A COL2A1 HTRA2 ARX DYRK1A DGKD GRIN2A EEF1D NAPB SIPA1L1 | 1.31e-05 | 360 | 157 | 15 | MP:0002064 |
| MousePheno | decreased locomotor activity | KIF1A CHRNA7 HNRNPH2 KCND3 NEGR1 VPS13A ANKRD28 DLG4 ATP13A3 CHRFAM7A BICC1 NEDD4L HTRA2 ARX ARHGEF12 FNDC3A GRM1 HIF1AN EEF1D FAM193A NAPB AKAP11 ATP1A2 IL1R1 | 1.74e-05 | 829 | 157 | 24 | MP:0001402 |
| MousePheno | abnormal anxiety-related response | TANC2 CHRNA7 HNRNPH2 KCND3 NEGR1 NAV2 DLG4 ATP13A3 CHRFAM7A ARX GRIN2A BTBD3 EEF1D DPP9 NAPB LMO1 SIPA1L1 AKAP11 ATP1A2 CSMD1 IL1R1 NIN | 2.72e-05 | 740 | 157 | 22 | MP:0001362 |
| MousePheno | neonatal lethality | KIF1A CHRNA7 FAT1 PTPRS CHRFAM7A SLC23A2 COL2A1 AKAP6 FAT4 COL11A1 NEDD4L UBR4 ARX DGKD SIK3 RUNX3 CLDN1 DPP9 CELSR3 ASS1 HLTF ATP1A2 | 8.53e-05 | 799 | 157 | 22 | MP:0002058 |
| MousePheno | abnormal seizure response to inducing agent | ARHGAP32 CHRNA7 HNRNPH2 PTPRO CHRFAM7A ARX DYRK1A GRIN2A EEF1D SIPA1L1 | 9.04e-05 | 201 | 157 | 10 | MP:0009357 |
| MousePheno | airway basal cell hyperplasia | 1.25e-04 | 2 | 157 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 1.25e-04 | 2 | 157 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 1.25e-04 | 2 | 157 | 2 | MP:0011113 | |
| MousePheno | loss of basal ganglia neurons | 1.25e-04 | 2 | 157 | 2 | MP:0003242 | |
| Domain | CADHERIN_1 | 2.42e-06 | 113 | 191 | 9 | PS00232 | |
| Domain | Cadherin | 2.42e-06 | 113 | 191 | 9 | PF00028 | |
| Domain | CADHERIN_2 | 2.61e-06 | 114 | 191 | 9 | PS50268 | |
| Domain | - | 2.61e-06 | 114 | 191 | 9 | 2.60.40.60 | |
| Domain | CA | 2.80e-06 | 115 | 191 | 9 | SM00112 | |
| Domain | Cadherin-like | 3.01e-06 | 116 | 191 | 9 | IPR015919 | |
| Domain | Cadherin | 3.47e-06 | 118 | 191 | 9 | IPR002126 | |
| Domain | LRRC37AB_C | 4.18e-06 | 4 | 191 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 4.18e-06 | 4 | 191 | 3 | PF14914 | |
| Domain | LRRC37_N | 4.18e-06 | 4 | 191 | 3 | IPR032754 | |
| Domain | LRRC37 | 4.18e-06 | 4 | 191 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 4.18e-06 | 4 | 191 | 3 | IPR015753 | |
| Domain | - | 5.87e-06 | 95 | 191 | 8 | 2.60.120.200 | |
| Domain | Cadherin_CS | 1.63e-05 | 109 | 191 | 8 | IPR020894 | |
| Domain | Ank | TANC2 NFKBIB TRPV2 ANKRD28 CAMTA1 ANKRD50 ANKRD55 ANKRD19P ANKRD11 MYO16 PPP1R16A | 2.37e-05 | 228 | 191 | 11 | PF00023 |
| Domain | Laminin_G | 2.75e-05 | 58 | 191 | 6 | IPR001791 | |
| Domain | EGF_CA | 3.68e-05 | 122 | 191 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.14e-05 | 124 | 191 | 8 | IPR001881 | |
| Domain | Laminin_G_2 | 5.22e-05 | 40 | 191 | 5 | PF02210 | |
| Domain | ANK | TANC2 NFKBIB TRPV2 ANKRD28 CAMTA1 ANKRD50 ANKRD55 ANKRD19P ANKRD11 MYO16 PPP1R16A | 5.71e-05 | 251 | 191 | 11 | SM00248 |
| Domain | ANK_REPEAT | TANC2 NFKBIB TRPV2 ANKRD28 CAMTA1 ANKRD50 ANKRD55 ANKRD19P ANKRD11 MYO16 PPP1R16A | 6.13e-05 | 253 | 191 | 11 | PS50088 |
| Domain | ANK_REP_REGION | TANC2 NFKBIB TRPV2 ANKRD28 CAMTA1 ANKRD50 ANKRD55 ANKRD19P ANKRD11 MYO16 PPP1R16A | 6.35e-05 | 254 | 191 | 11 | PS50297 |
| Domain | LamG | 8.34e-05 | 44 | 191 | 5 | SM00282 | |
| Domain | Ankyrin_rpt | TANC2 NFKBIB TRPV2 ANKRD28 CAMTA1 ANKRD50 ANKRD55 ANKRD19P ANKRD11 MYO16 PPP1R16A | 8.38e-05 | 262 | 191 | 11 | IPR002110 |
| Domain | TPR-like_helical_dom | TANC2 NAPA SEL1L3 KDM6A RGPD5 RANBP2 RGPD8 PPP5C NAPB CFAP46 | 1.47e-04 | 233 | 191 | 10 | IPR011990 |
| Domain | Ran_BP1 | 2.16e-04 | 12 | 191 | 3 | PF00638 | |
| Domain | RANBD1 | 2.16e-04 | 12 | 191 | 3 | PS50196 | |
| Domain | - | TANC2 NFKBIB TRPV2 ANKRD28 CAMTA1 ANKRD50 ANKRD55 ANKRD11 MYO16 PPP1R16A | 2.44e-04 | 248 | 191 | 10 | 1.25.40.20 |
| Domain | RanBD | 2.79e-04 | 13 | 191 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 2.79e-04 | 13 | 191 | 3 | IPR000156 | |
| Domain | - | 2.87e-04 | 207 | 191 | 9 | 1.25.40.10 | |
| Domain | Ankyrin_rpt-contain_dom | TANC2 NFKBIB TRPV2 ANKRD28 CAMTA1 ANKRD50 ANKRD55 ANKRD11 MYO16 PPP1R16A | 2.96e-04 | 254 | 191 | 10 | IPR020683 |
| Domain | TPR_REGION | 3.02e-04 | 165 | 191 | 8 | PS50293 | |
| Domain | TPR | 3.02e-04 | 165 | 191 | 8 | PS50005 | |
| Domain | Znf_CHHC | 3.10e-04 | 3 | 191 | 2 | IPR012996 | |
| Domain | NSF_attach | 3.10e-04 | 3 | 191 | 2 | IPR000744 | |
| Domain | zf-RNPHF | 3.10e-04 | 3 | 191 | 2 | PF08080 | |
| Domain | DAGKc | 3.53e-04 | 14 | 191 | 3 | SM00046 | |
| Domain | Ank_2 | TANC2 NFKBIB TRPV2 ANKRD28 ANKRD50 ANKRD55 ANKRD11 MYO16 PPP1R16A | 3.80e-04 | 215 | 191 | 9 | PF12796 |
| Domain | ConA-like_dom | 4.34e-04 | 219 | 191 | 9 | IPR013320 | |
| Domain | Diacylglycerol_kinase_cat_dom | 4.38e-04 | 15 | 191 | 3 | IPR001206 | |
| Domain | DAGK | 4.38e-04 | 15 | 191 | 3 | PS50146 | |
| Domain | DAGK_cat | 4.38e-04 | 15 | 191 | 3 | PF00781 | |
| Domain | LAM_G_DOMAIN | 5.96e-04 | 38 | 191 | 4 | PS50025 | |
| Domain | NAD/diacylglycerol_kinase | 6.44e-04 | 17 | 191 | 3 | IPR016064 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.73e-04 | 106 | 191 | 6 | IPR000152 | |
| Domain | Kinesin_motor_CS | 7.98e-04 | 41 | 191 | 4 | IPR019821 | |
| Domain | TPR-contain_dom | 9.01e-04 | 150 | 191 | 7 | IPR013026 | |
| Domain | - | 1.05e-03 | 44 | 191 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 1.05e-03 | 44 | 191 | 4 | PF00225 | |
| Domain | KISc | 1.05e-03 | 44 | 191 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.05e-03 | 44 | 191 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.05e-03 | 44 | 191 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.05e-03 | 44 | 191 | 4 | PS50067 | |
| Domain | EGF_CA | 1.89e-03 | 86 | 191 | 5 | PF07645 | |
| Domain | KA1/Ssp2_C | 2.11e-03 | 7 | 191 | 2 | IPR028375 | |
| Domain | TPR_1 | 2.31e-03 | 90 | 191 | 5 | IPR001440 | |
| Domain | TPR_1 | 2.31e-03 | 90 | 191 | 5 | PF00515 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.19e-06 | 20 | 139 | 5 | MM1445 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.55e-06 | 21 | 139 | 5 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.00e-06 | 22 | 139 | 5 | MM15104 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 4.21e-06 | 12 | 139 | 4 | MM15142 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 9.25e-06 | 5 | 139 | 3 | MM14493 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 1.84e-05 | 6 | 139 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 1.84e-05 | 6 | 139 | 3 | MM15662 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.22e-05 | 35 | 139 | 5 | MM15109 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 3.19e-05 | 7 | 139 | 3 | MM1357 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 7.55e-05 | 9 | 139 | 3 | M3412 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 8.91e-05 | 144 | 139 | 8 | MM14501 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 1.02e-04 | 76 | 139 | 6 | M9052 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 1.07e-04 | 10 | 139 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 1.07e-04 | 10 | 139 | 3 | M47954 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 1.10e-04 | 77 | 139 | 6 | MM14513 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 1.46e-04 | 11 | 139 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.46e-04 | 11 | 139 | 3 | M47958 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 1.93e-04 | 12 | 139 | 3 | MM14817 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 1.93e-04 | 12 | 139 | 3 | M47956 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP32 STARD8 INCENP CENPC PIK3C3 DLG4 DOCK1 RANBP2 RGPD8 CALM1 NUP107 CALM2 CALM3 DOCK10 ARHGEF12 CPD RACGAP1 | 2.20e-04 | 649 | 139 | 17 | MM15690 |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | INCENP CENPC PIK3C3 DLG4 RANBP2 RGPD8 CALM1 NUP107 CALM2 CALM3 | 2.31e-04 | 257 | 139 | 10 | MM14755 |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 2.50e-04 | 13 | 139 | 3 | MM15078 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.63e-04 | 32 | 139 | 4 | MM15143 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 3.15e-04 | 14 | 139 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 3.15e-04 | 14 | 139 | 3 | M47388 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 3.15e-04 | 14 | 139 | 3 | MM15052 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 3.15e-04 | 14 | 139 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 3.15e-04 | 14 | 139 | 3 | MM15391 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.31e-04 | 61 | 139 | 5 | MM14637 | |
| Pathway | REACTOME_RAF_ACTIVATION | 3.74e-04 | 35 | 139 | 4 | MM15271 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 3.91e-04 | 15 | 139 | 3 | M47385 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 3.91e-04 | 15 | 139 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 3.91e-04 | 15 | 139 | 3 | MM14795 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 3.91e-04 | 15 | 139 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 3.91e-04 | 15 | 139 | 3 | MM15103 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.13e-04 | 98 | 139 | 6 | MM15352 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.60e-04 | 100 | 139 | 6 | M27650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 4.78e-04 | 16 | 139 | 3 | MM14492 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 4.78e-04 | 16 | 139 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 4.78e-04 | 16 | 139 | 3 | M47449 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | GABRR1 CHRNA7 KCND3 PTPRS DLG4 CHRFAM7A CALM1 CALM2 CALM3 GRIN2A GRM1 | 4.83e-04 | 335 | 139 | 11 | MM14503 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.13e-04 | 67 | 139 | 5 | M26999 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 5.76e-04 | 17 | 139 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 5.76e-04 | 17 | 139 | 3 | M47387 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 5.76e-04 | 17 | 139 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 5.76e-04 | 17 | 139 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 5.76e-04 | 17 | 139 | 3 | M2349 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 5.76e-04 | 17 | 139 | 3 | M47560 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 6.28e-04 | 70 | 139 | 5 | M3115 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 6.87e-04 | 18 | 139 | 3 | MM1385 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 6.87e-04 | 18 | 139 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 6.87e-04 | 18 | 139 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 6.87e-04 | 18 | 139 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 6.87e-04 | 18 | 139 | 3 | M3430 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 6.91e-04 | 41 | 139 | 4 | MM15538 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE | 8.10e-04 | 19 | 139 | 3 | M47885 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 8.10e-04 | 19 | 139 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 8.10e-04 | 19 | 139 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 8.10e-04 | 19 | 139 | 3 | M47957 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 9.05e-04 | 44 | 139 | 4 | M27812 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 9.14e-04 | 76 | 139 | 5 | MM14573 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 9.46e-04 | 20 | 139 | 3 | MM15485 | |
| Pathway | BIOCARTA_RAN_PATHWAY | 9.47e-04 | 5 | 139 | 2 | M22082 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.01e-03 | 116 | 139 | 6 | MM15715 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.10e-03 | 21 | 139 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 1.10e-03 | 21 | 139 | 3 | M27944 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.10e-03 | 21 | 139 | 3 | M27736 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.10e-03 | 21 | 139 | 3 | M47542 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.16e-03 | 211 | 139 | 8 | MM14502 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 1.26e-03 | 22 | 139 | 3 | MM15519 | |
| Pathway | REACTOME_CHOLINE_CATABOLISM | 1.41e-03 | 6 | 139 | 2 | MM15329 | |
| Pathway | REACTOME_CHOLINE_CATABOLISM | 1.41e-03 | 6 | 139 | 2 | M27619 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.44e-03 | 23 | 139 | 3 | MM15222 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 1.44e-03 | 23 | 139 | 3 | M27949 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.44e-03 | 23 | 139 | 3 | M47512 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.47e-03 | 50 | 139 | 4 | MM14796 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 1.47e-03 | 50 | 139 | 4 | M39822 | |
| Pathway | REACTOME_HEMOSTASIS | KIF1A DGKG LY6G6F KIF9 DOCK1 CALM1 CALM2 CALM3 RAPGEF4 KIF16B DOCK10 DGKD THBS1 RACGAP1 | 1.52e-03 | 571 | 139 | 14 | MM14472 |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.58e-03 | 51 | 139 | 4 | MM15151 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.63e-03 | 24 | 139 | 3 | M47509 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.68e-03 | 87 | 139 | 5 | M27617 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.82e-03 | 53 | 139 | 4 | MM14566 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 1.84e-03 | 25 | 139 | 3 | M1547 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 1.84e-03 | 25 | 139 | 3 | MM15574 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 1.84e-03 | 25 | 139 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.84e-03 | 25 | 139 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.84e-03 | 25 | 139 | 3 | M47511 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 1.88e-03 | 131 | 139 | 6 | MM15717 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 1.88e-03 | 131 | 139 | 6 | MM15497 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.92e-03 | 178 | 139 | 7 | M2890 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.95e-03 | 90 | 139 | 5 | M631 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.95e-03 | 54 | 139 | 4 | MM15202 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 2.07e-03 | 26 | 139 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 2.07e-03 | 26 | 139 | 3 | M17941 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.07e-03 | 26 | 139 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.07e-03 | 26 | 139 | 3 | MM1371 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 2.07e-03 | 26 | 139 | 3 | MM1431 | |
| Pathway | WP_IL1_SIGNALING | 2.09e-03 | 55 | 139 | 4 | M39346 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.11e-03 | 134 | 139 | 6 | M27751 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 2.24e-03 | 56 | 139 | 4 | M27616 | |
| Pubmed | TANC2 ARHGAP32 DDB1 TENM2 PTPRS PRRC2C ANKRD28 DLG4 WNK3 GOLGB1 RANBP2 NEDD4L RGPD8 CALM1 CALM2 UBR4 RAPGEF4 DYRK1A NSD1 ARHGEF12 GRIN2A SIK3 SIPA1 GRM1 CELSR2 SIPA1L1 RACGAP1 | 1.13e-11 | 963 | 199 | 27 | 28671696 | |
| Pubmed | KMT2C NAV2 ANKRD28 CAMTA1 SLC23A2 AKAP6 DOCK10 FNDC3A SIK3 SIPA1L1 AKAP11 SNRNP200 NIN | 7.03e-10 | 225 | 199 | 13 | 12168954 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 ARHGAP32 MARK3 DENND2B MAP3K3 PIK3C3 STARD9 PRRC2C NAV2 WNK3 BICC1 GOLGB1 NEDD4L DYRK1A SIK3 SIPA1L1 PRKAA2 ASS1 ANKRD11 RACGAP1 AKAP11 CRYBG3 PALLD | 1.08e-09 | 861 | 199 | 23 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SPTLC3 KIF1A MARK3 NAPA PSMD1 DENND2B TASOR2 KMT2C KCND3 PIK3C3 PTPRS SEL1L3 CAMTA1 KDM6A GOLGB1 DOCK1 NEDD4L ANXA7 TUSC3 ZBTB8A CPD ABCG1 DPP9 PRKAA2 ASS1 ANKRD11 LRBA CSMD1 | 3.36e-08 | 1489 | 199 | 28 | 28611215 |
| Pubmed | Nicotine regulates multiple synaptic proteins by inhibiting proteasomal activity. | 3.59e-08 | 7 | 199 | 4 | 17898222 | |
| Pubmed | TANC2 ARHGAP32 SANBR DGKG PSMD1 TENM2 HNRNPH2 KCND3 PRRC2C ANKRD28 DLG4 RANBP2 NEDD4L RGPD8 CALM1 CALM2 UBR4 GRIN2A EEF1D CELSR2 PPP5C SIPA1L1 CRYBG3 ATP1A2 | 4.40e-08 | 1139 | 199 | 24 | 36417873 | |
| Pubmed | CLSTN3 ZBTB38 KIF1A NAPA PSMD1 MIA2 DLG4 KDM6A AKAP6 CALM1 ANXA7 UBR4 RAPGEF4 DYRK1A ZNF181 THBS1 CELSR3 PPP5C NAPB SIPA1L1 KDM4A LRBA ATP1A2 ST18 SNRNP200 | 1.04e-07 | 1285 | 199 | 25 | 35914814 | |
| Pubmed | CLSTN3 MARK3 TENM2 NEGR1 STARD9 PRRC2C SEL1L3 CAMTA1 SLC23A2 NEDD4L DOCK10 ARHGEF12 SIPA1L1 ST18 | 1.12e-07 | 407 | 199 | 14 | 12693553 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 29932249 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 1.85e-07 | 3 | 199 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 1.85e-07 | 3 | 199 | 3 | 9923700 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 1.85e-07 | 3 | 199 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 1.85e-07 | 3 | 199 | 3 | 8573130 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 10899953 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 1.85e-07 | 3 | 199 | 3 | 9278050 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 1.85e-07 | 3 | 199 | 3 | 11847276 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 10416864 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 7828884 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 8862395 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 1.85e-07 | 3 | 199 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 1.85e-07 | 3 | 199 | 3 | 15632291 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 1.85e-07 | 3 | 199 | 3 | 8631777 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 18553937 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 14978283 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 1.85e-07 | 3 | 199 | 3 | 11054265 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 33191766 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 18940602 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 25268113 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 19651602 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 26969752 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 1.85e-07 | 3 | 199 | 3 | 11807546 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 8312049 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 37380439 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 24491550 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 1.85e-07 | 3 | 199 | 3 | 11710561 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 1.85e-07 | 3 | 199 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 1.85e-07 | 3 | 199 | 3 | 3384819 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 21799007 | ||
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 1.85e-07 | 3 | 199 | 3 | 20956522 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 1.85e-07 | 3 | 199 | 3 | 18786401 | |
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 11072229 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 16229872 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 15063758 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 8226798 | ||
| Pubmed | 1.85e-07 | 3 | 199 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 1.85e-07 | 3 | 199 | 3 | 17582331 | |
| Pubmed | Direct interaction of myosin regulatory light chain with the NMDA receptor. | 2.13e-07 | 10 | 199 | 4 | 15663482 | |
| Pubmed | 3.71e-07 | 49 | 199 | 6 | 34368113 | ||
| Pubmed | SANBR KMT2C NAV2 AKAP6 KIF16B FNDC3A SIK3 ANKRD50 MIER1 CELSR3 RACGAP1 AKAP11 KDM4A ATP1A2 NIN | 4.63e-07 | 529 | 199 | 15 | 14621295 | |
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 7.35e-07 | 4 | 199 | 3 | 7607248 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 27516456 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 7.35e-07 | 4 | 199 | 3 | 23040497 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 16299511 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 25437912 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 7.35e-07 | 4 | 199 | 3 | 15499021 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 10692436 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 16478480 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 22419166 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 7.35e-07 | 4 | 199 | 3 | 16127172 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 20226167 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 10823944 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 7.35e-07 | 4 | 199 | 3 | 25519244 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 7.35e-07 | 4 | 199 | 3 | 14960328 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 22405011 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 7.35e-07 | 4 | 199 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 7.35e-07 | 4 | 199 | 3 | 11807557 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 11286509 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 20953164 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 19855925 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 7.35e-07 | 4 | 199 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 7.35e-07 | 4 | 199 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 7.35e-07 | 4 | 199 | 3 | 8780394 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 19279214 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 7.35e-07 | 4 | 199 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 7.35e-07 | 4 | 199 | 3 | 20103772 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 9096366 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 12577052 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 9480752 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 7.35e-07 | 4 | 199 | 3 | 22067155 | |
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 25441029 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 16505387 | ||
| Pubmed | 7.35e-07 | 4 | 199 | 3 | 26164367 | ||
| Pubmed | TANC2 ARHGAP32 MARK3 DDB1 HNRNPH1 KCND3 NEGR1 PTPRS PRRC2C DLG4 USP4 NEDD4L IGHV1-45 RAPGEF4 DYRK1A ARHGEF12 GRIN2A SIPA1 GRM1 EEF1D NAPB MTERF2 SIPA1L1 ATP1A2 SNRNP200 | 7.60e-07 | 1431 | 199 | 25 | 37142655 | |
| Pubmed | ARHGAP32 MARK3 PSMD1 DDB1 HNRNPH1 PRRC2C GOLGB1 DOCK1 RANBP2 ARHGEF12 FNDC3A CPD ANKRD50 CRYBG3 LRBA SNRNP200 PALLD | 7.89e-07 | 708 | 199 | 17 | 39231216 | |
| Pubmed | CENPC FAM178B SANBR PSMD1 RCC1 TASOR2 MIA2 STARD9 PRRC2C VPS13A NAV2 MNDA GOLGB1 RGPD5 RANBP2 RGPD8 PCDHGA11 PCDHGA7 UBR4 REL EEF1D SMARCA1 ATP1A2 IL1R1 CFAP46 | 8.73e-07 | 1442 | 199 | 25 | 35575683 | |
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 1.21e-06 | 94 | 199 | 7 | 23431145 | |
| Pubmed | MYL1 DDB1 USP4 GAPDHS DMGDH ANXA7 UBR4 FNDC3A EEF1D LRBA SNRNP200 | 1.63e-06 | 304 | 199 | 11 | 32235678 | |
| Pubmed | 1.83e-06 | 5 | 199 | 3 | 27165696 | ||
| Pubmed | 1.83e-06 | 5 | 199 | 3 | 11981030 | ||
| Pubmed | Rab3B in human platelet is membrane bound and interacts with Ca(2+)/calmodulin. | 1.83e-06 | 5 | 199 | 3 | 11741295 | |
| Interaction | DCANP1 interactions | 8.83e-07 | 19 | 197 | 5 | int:DCANP1 | |
| Interaction | NUP210P1 interactions | 3.16e-06 | 42 | 197 | 6 | int:NUP210P1 | |
| Interaction | YWHAH interactions | TANC2 ARHGAP32 MARK3 DENND2B MAP3K3 PIK3C3 STARD9 PRRC2C NAV2 USP4 WNK3 BICC1 NEDD4L DYRK1A SIK3 SIPA1 ANKRD55 SIPA1L1 PRKAA2 ASS1 ANKRD11 RACGAP1 AKAP11 CRYBG3 LRBA CDC25A PALLD NIN | 3.40e-06 | 1102 | 197 | 28 | int:YWHAH |
| Interaction | SPSB4 interactions | 3.66e-06 | 124 | 197 | 9 | int:SPSB4 | |
| Interaction | YWHAQ interactions | TANC2 ARHGAP32 ZBTB38 MARK3 PSMD1 DENND2B HNRNPH1 MAP3K3 PIK3C3 STARD9 NAV2 BICC1 GOLGB1 NEDD4L CALM1 NUP107 HUS1 DYRK1A SIK3 SIPA1 ANKRD55 ACE2 PPP5C SIPA1L1 RACGAP1 AKAP11 LRBA CDC25A | 4.47e-06 | 1118 | 197 | 28 | int:YWHAQ |
| Interaction | ELFN2 interactions | 8.32e-06 | 29 | 197 | 5 | int:ELFN2 | |
| Interaction | FOXK2 interactions | TANC2 HNRNPH1 PRRC2C ANKRD28 KDM6A NUP107 UBR4 CPD SMARCA1 ELF1 SNRNP200 | 1.40e-05 | 225 | 197 | 11 | int:FOXK2 |
| Interaction | KCNA3 interactions | ARHGAP32 MARK3 PSMD1 DDB1 HNRNPH1 KMT2C PRRC2C VPS13A DLG4 GOLGB1 DOCK1 RANBP2 NEDD4L DOCK10 ARHGEF12 FNDC3A CPD ANKRD50 SIPA1L1 CRYBG3 LRBA SNRNP200 PALLD | 1.50e-05 | 871 | 197 | 23 | int:KCNA3 |
| Interaction | NPIPB6 interactions | 2.43e-05 | 18 | 197 | 4 | int:NPIPB6 | |
| Interaction | CAMTA2 interactions | 2.43e-05 | 18 | 197 | 4 | int:CAMTA2 | |
| Interaction | TAMALIN interactions | 3.06e-05 | 19 | 197 | 4 | int:TAMALIN | |
| Interaction | NPAS1 interactions | HAUS3 USP4 KNL1 RGPD5 RGPD8 NLRP2 THBS1 ANKRD11 AKAP11 CRYBG3 LRBA | 3.08e-05 | 245 | 197 | 11 | int:NPAS1 |
| Interaction | SPATA17 interactions | 3.13e-05 | 7 | 197 | 3 | int:SPATA17 | |
| Interaction | UBE3C interactions | PSMD1 PTPRO PIK3C3 CALM1 CALM2 CALM3 ANXA7 ANKRD55 GRSF1 LRRC25 | 3.38e-05 | 204 | 197 | 10 | int:UBE3C |
| Interaction | XAGE1A interactions | 4.78e-05 | 41 | 197 | 5 | int:XAGE1A | |
| Interaction | KCNN1 interactions | 4.97e-05 | 8 | 197 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 4.97e-05 | 8 | 197 | 3 | int:ARPP21 | |
| Interaction | GSK3A interactions | MARK3 LRRC37A2 PSMD1 RCC1 MYPN ANKRD28 FLT3 ARHGEF12 FAM193A PPP5C SIPA1L1 AKAP11 CRYBG3 PALLD NIN | 5.46e-05 | 464 | 197 | 15 | int:GSK3A |
| Interaction | YWHAB interactions | TANC2 ARHGAP32 MARK3 DENND2B MAP3K3 STARD9 NAV2 DLG4 USP4 NEDD4L CALM1 NUP107 DYRK1A SIK3 SIPA1 ANKRD55 ACE2 PPP5C SIPA1L1 PRKAA2 RACGAP1 AKAP11 CDC25A SNRNP200 | 5.64e-05 | 1014 | 197 | 24 | int:YWHAB |
| Interaction | RANBP2 interactions | PSMD1 RCC1 HNRNPH1 PIK3C3 USP4 RGPD5 RANBP2 RGPD8 CALM1 NUP107 ANKRD55 ACE2 SNRNP200 | 5.88e-05 | 361 | 197 | 13 | int:RANBP2 |
| Interaction | AMOT interactions | ANKRD28 NEDD4L CALM3 UBR4 KIF16B FNDC3A ACE2 FAM193A SIPA1L1 PRKAA2 CRYBG3 NIN | 6.08e-05 | 312 | 197 | 12 | int:AMOT |
| Interaction | SMC1A interactions | HAUS3 DDB1 HNRNPH1 PTPRS ANKRD28 FLT3 ANKRD55 ACE2 PRKAA2 ANKRD11 HLTF ELF1 RPGR SNRNP200 | 6.67e-05 | 418 | 197 | 14 | int:SMC1A |
| Interaction | IQSEC2 interactions | 6.76e-05 | 44 | 197 | 5 | int:IQSEC2 | |
| Interaction | USP7 interactions | ZBTB38 HNRNPH1 HNRNPH2 NUTM1 MYPN NAV2 KDM6A WNK3 GOLGB1 NEDD4L RGPD8 HTRA2 DYRK1A DOCK10 NSD1 REL GRM1 ANKRD55 HIF1AN ACE2 EEF1D TMEM132D SMARCA1 HLTF RPGR LRBA CDC25A SNRNP200 | 8.13e-05 | 1313 | 197 | 28 | int:USP7 |
| Interaction | RGPD8 interactions | 8.62e-05 | 74 | 197 | 6 | int:RGPD8 | |
| Interaction | RGPD3 interactions | 9.32e-05 | 47 | 197 | 5 | int:RGPD3 | |
| Interaction | TSPOAP1 interactions | 9.54e-05 | 25 | 197 | 4 | int:TSPOAP1 | |
| Interaction | CAMKK1 interactions | 1.03e-04 | 48 | 197 | 5 | int:CAMKK1 | |
| Interaction | IQCG interactions | 1.05e-04 | 10 | 197 | 3 | int:IQCG | |
| Interaction | PCDHGB1 interactions | 1.08e-04 | 77 | 197 | 6 | int:PCDHGB1 | |
| Interaction | RGPD1 interactions | 1.14e-04 | 49 | 197 | 5 | int:RGPD1 | |
| Interaction | PCNT interactions | 1.36e-04 | 241 | 197 | 10 | int:PCNT | |
| Interaction | NUP43 interactions | INCENP CENPC DDB1 TASOR2 PRRC2C ANKRD28 KNL1 RGPD5 RANBP2 RGPD8 NUP107 NSD1 SMARCA1 ANKRD11 HLTF ELF1 SNRNP200 | 1.45e-04 | 625 | 197 | 17 | int:NUP43 |
| Interaction | SIRT6 interactions | DDB1 HNRNPH1 HNRNPH2 TASOR2 FAT1 RGPD5 RANBP2 FAT4 RGPD8 NUP107 HUS1 DYRK1A NLRP2 CELSR3 CELSR2 SNRNP200 PALLD | 1.53e-04 | 628 | 197 | 17 | int:SIRT6 |
| Interaction | VASP interactions | XIRP1 DDB1 HNRNPH1 FAT1 ANKRD28 UBR4 DYRK1A ARHGEF12 UTP4 SIPA1L1 PALLD | 1.57e-04 | 294 | 197 | 11 | int:VASP |
| Interaction | CAMK1D interactions | 1.82e-04 | 54 | 197 | 5 | int:CAMK1D | |
| Cytoband | 15q14 | 6.23e-05 | 49 | 199 | 4 | 15q14 | |
| Cytoband | 1p21 | 1.52e-04 | 24 | 199 | 3 | 1p21 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.14e-05 | 115 | 140 | 7 | 769 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.39e-05 | 181 | 140 | 8 | 694 | |
| GeneFamily | Ankyrin repeat domain containing | TANC2 NFKBIB TRPV2 ANKRD28 ANKRD50 ANKRD55 ANKRD11 MYO16 PPP1R16A | 1.14e-04 | 242 | 140 | 9 | 403 |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.78e-04 | 3 | 140 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.78e-04 | 3 | 140 | 2 | 1189 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.60e-04 | 161 | 140 | 7 | 593 | |
| GeneFamily | Cadherin related | 2.85e-04 | 17 | 140 | 3 | 24 | |
| GeneFamily | Collagens | 4.37e-04 | 46 | 140 | 4 | 490 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.37e-04 | 46 | 140 | 4 | 622 | |
| GeneFamily | PDZ domain containing | 1.19e-03 | 152 | 140 | 6 | 1220 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 2.57e-03 | 10 | 140 | 2 | 1178 | |
| GeneFamily | Annexins|Endogenous ligands | 4.39e-03 | 13 | 140 | 2 | 404 | |
| GeneFamily | StAR related lipid transfer domain containing | 5.85e-03 | 15 | 140 | 2 | 759 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPC MARK3 DENND2B FAT1 MIA2 PIK3C3 PRRC2C VPS13A ANKRD28 ATP13A3 SLC23A2 DOCK1 RANBP2 PARG DYRK1A FNDC3A SIK3 FAM193A SIPA1L1 SMARCA1 HLTF AKAP11 RPGR CRYBG3 IL1R1 | 8.23e-09 | 856 | 198 | 25 | M4500 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZBTB38 STARD8 CCDC126 GIMAP1 TENM2 DENND2B MAP3K3 KMT2C PTPRO VPS13A KDM6A MNDA ING3 CALM1 CALM2 RAPGEF4 ZBTB8A FNDC3A BTBD3 TMEM106B THBS1 ELF1 LRBA PALLD | 7.18e-08 | 888 | 198 | 24 | MM1018 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZBTB38 STARD8 CCDC126 GIMAP1 TENM2 DENND2B MAP3K3 KMT2C PTPRO VPS13A KDM6A ING3 CALM1 CALM2 RAPGEF4 ZBTB8A FNDC3A BTBD3 TMEM106B THBS1 ELF1 LRBA PALLD | 1.46e-07 | 854 | 198 | 23 | M1533 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CLSTN3 ZBTB38 CENPC MARK3 GIMAP1 HNRNPH1 KMT2C SEL1L3 TRPV2 ANKRD28 RANBP2 CALM1 CALM3 UBR4 DYRK1A DOCK10 NSD1 SIK3 SIPA1 RUNX3 MIER1 EEF1D SYTL3 ANKRD11 ELF1 AKAP11 LRBA SNRNP200 NIN | 2.82e-06 | 1492 | 198 | 29 | M40023 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 4.67e-06 | 33 | 198 | 5 | MM477 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | TANC2 ZBTB38 KIF1A CENPC NAPA PSMD1 KMT2C NAV2 GOLGB1 RANBP2 DOCK10 DGKD CPD CDCP1 BTBD3 ABCG1 MTERF2 HLTF AKAP11 ST18 NIN | 1.08e-05 | 946 | 198 | 21 | M39169 |
| Coexpression | EIF4E_DN | 1.12e-05 | 100 | 198 | 7 | M2790 | |
| Coexpression | GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN | 1.93e-05 | 196 | 198 | 9 | M5791 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 2.49e-05 | 46 | 198 | 5 | MM670 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP | 2.50e-05 | 23 | 198 | 4 | MM694 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 4.18e-05 | 167 | 198 | 8 | M361 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 4.84e-05 | 27 | 198 | 4 | M14833 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 6.70e-05 | 11 | 198 | 3 | M47997 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | SPTLC3 CHDH FAT1 KIF9 MIA2 PIK3C3 SEL1L3 CAMTA1 BICC1 FNDC3A SIPA1L1 PRKAA2 | 6.75e-05 | 407 | 198 | 12 | M2214 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.10e-05 | 180 | 198 | 8 | M8239 | |
| Coexpression | GABRIELY_MIR21_TARGETS | ZBTB38 VPS13A ANKRD28 WNK3 KNL1 DOCK10 ARHGEF12 BTBD3 CDC25A PALLD | 7.46e-05 | 289 | 198 | 10 | M2196 |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | PSMD1 HNRNPH2 PRRC2C SEL1L3 ANKRD28 GAPDHS MNDA CALM2 CALM3 ANXA7 PARG DYRK1A ASS1 HLTF KDM4A SNRNP200 | 9.76e-05 | 705 | 198 | 16 | M1410 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 ZBTB38 KIF1A TENM2 PTPRO NEGR1 CAMTA1 WNK3 AKAP6 COL11A1 NEDD4L COL6A6 ARHGEF12 SIK3 GRM1 CELSR3 NAPB PRKAA2 CSMD1 CDH4 ARMH4 | 1.03e-04 | 1106 | 198 | 21 | M39071 |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 1.07e-04 | 191 | 198 | 8 | M40019 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | TANC2 KIF1A LRRC37A3 FAM178B DGKG TENM2 KMT2C NAV2 GAPDHS CAMTA1 RGPD8 ZBTB8A RUNX3 CLDN1 SYTL3 TMEM132D ST18 CDH4 | 1.20e-04 | 873 | 198 | 18 | M16009 |
| Coexpression | WANG_LMO4_TARGETS_UP | RGMB MAP3K3 KMT2C ATP13A3 TUSC3 DYRK1A ARHGEF12 ANKRD55 TMEM106B THBS1 IL1R1 | 1.29e-04 | 371 | 198 | 11 | M4735 |
| Coexpression | GSE3982_DC_VS_BCELL_DN | 1.33e-04 | 197 | 198 | 8 | M5470 | |
| Coexpression | GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN | 1.42e-04 | 199 | 198 | 8 | M8415 | |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | ARHGAP32 CHDH HAUS3 ANKRD28 USP4 CAMTA1 UBR4 ARHGEF12 ZBTB8A SIK3 RUNX3 MIER1 HIF1AN FAM193A ZNF436 KDM4A CDC25A | 1.45e-04 | 807 | 198 | 17 | M14594 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ZBTB38 CENPC HAUS3 TASOR2 GOLGB1 KNL1 KIF16B DOCK10 CDH19 CLDN1 HLTF AKAP11 RPGR PALLD NIN | 1.49e-04 | 656 | 198 | 15 | M18979 |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.79e-06 | 75 | 195 | 7 | gudmap_kidney_P1_CapMes_Crym_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | DENND2B BNC1 FAT1 KCND3 PTPRS SEL1L3 WNK3 BICC1 KNL1 ARX DOCK10 GRIN2A ACE2 THBS1 HMCN1 ASS1 SMARCA1 RACGAP1 IL1R1 PALLD ARMH4 | 1.39e-05 | 793 | 195 | 21 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_100 | 1.44e-05 | 86 | 195 | 7 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TANC2 SPTLC3 RGMB MYL1 TENM2 PTPRO NEGR1 PTPRS ATP13A3 DOCK1 FAT4 RAPGEF4 DYRK1A DGKD CPD THBS1 FAM193A CELSR3 NAPB SIPA1L1 ARMH4 | 2.19e-05 | 818 | 195 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | RGMB ARHGAP32 SANBR GIMAP1 TENM2 KCND3 PTPRO NEGR1 SEL1L3 ANKRD28 ATP13A3 CAMTA1 COL13A1 DOCK10 ARHGEF12 ZBTB8A ACE2 CELSR2 HLTF CDH4 NIN | 3.02e-05 | 836 | 195 | 21 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.19e-05 | 66 | 195 | 6 | gudmap_kidney_P2_CapMes_Crym_k3_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 4.43e-05 | 22 | 195 | 4 | gudmap_kidney_P0_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | RGMB MYL1 TENM2 PTPRO PRRC2C VPS13A ATP13A3 BICC1 DOCK1 NSD1 DGKD CPD CDCP1 ELL3 THBS1 FAM193A CELSR2 NAPB HLTF CDH4 | 4.62e-05 | 795 | 195 | 20 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 8.80e-05 | 26 | 195 | 4 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k2_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#4_top-relative-expression-ranked_1000 | RGMB ARHGAP32 SANBR SEL1L3 ANKRD28 CAMTA1 COL13A1 DOCK10 ARHGEF12 CDH4 NIN | 8.85e-05 | 293 | 195 | 11 | gudmap_developingKidney_e15.5_Podocyte cells_1000_k4 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TANC2 DENND2B BNC1 KCND3 PTPRS DLG4 WNK3 BICC1 KNL1 ARX GRIN2A ACE2 THBS1 HMCN1 ASS1 SMARCA1 IL1R1 PALLD ARMH4 | 1.04e-04 | 777 | 195 | 19 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | RCC1 PTPRO SEL1L3 DLG4 CAMTA1 BICC1 KNL1 ARHGEF12 CLDN1 CELSR2 PRKAA2 SCPEP1 NEIL3 RPGR CRYBG3 LRBA CDH4 RAI2 NIN | 1.15e-04 | 783 | 195 | 19 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | ZNF142 BNC1 KMT2C KCND3 STARD9 PRRC2C NAV2 KDM6A BICC1 KNL1 COL11A1 COL13A1 ARX CPD ACE2 ANKRD11 SCPEP1 NEIL3 ATP1A2 | 1.30e-04 | 790 | 195 | 19 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.33e-04 | 85 | 195 | 6 | gudmap_kidney_P0_CapMes_Crym_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_200 | 1.61e-04 | 88 | 195 | 6 | gudmap_developingKidney_e15.5_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 2.31e-04 | 94 | 195 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TANC2 RGMB PTPRS ATP13A3 DOCK1 RAPGEF4 DYRK1A DGKD CPD THBS1 FAM193A NAPB | 2.43e-04 | 385 | 195 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 2.58e-04 | 34 | 195 | 4 | gudmap_kidney_P2_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_1000 | EXTL2 NEGR1 SEL1L3 DLG4 ATP13A3 CAMTA1 BICC1 CLDN1 THBS1 HMCN1 SIPA1L1 SCPEP1 NEIL3 CRYBG3 CDH4 RAI2 | 2.72e-04 | 636 | 195 | 16 | gudmap_kidney_P2_CapMes_Crym_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | EXTL2 NEGR1 SEL1L3 DLG4 ATP13A3 CAMTA1 BICC1 CLDN1 THBS1 HMCN1 SIPA1L1 NEIL3 RPGR CRYBG3 CDH4 RAI2 | 2.87e-04 | 639 | 195 | 16 | gudmap_kidney_P0_CapMes_Crym_1000 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | HNRNPH1 TASOR2 KMT2C ATP13A3 KDM6A GOLGB1 RANBP2 DYRK1A DOCK10 REL SIK3 ANKRD11 LRBA | 3.27e-12 | 188 | 199 | 13 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MIA2 PRRC2C KDM6A PARG DOCK10 NSD1 REL MIER1 THBS1 ANKRD11 ELF1 | 7.46e-10 | 184 | 199 | 11 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-10 | 185 | 199 | 11 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | FAT1 NEGR1 PTPRS NAV2 ATP13A3 RANBP2 REL SIK3 CDH19 THBS1 IL1R1 | 9.91e-10 | 189 | 199 | 11 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIF1A DDB1 KMT2C PRRC2C VPS13A NAV2 GOLGB1 COL6A6 RAPGEF4 ANKRD11 ST18 | 1.38e-09 | 195 | 199 | 11 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIF1A KMT2C PRRC2C VPS13A NAV2 GOLGB1 COL6A6 RAPGEF4 NSD1 ANKRD11 ST18 | 1.38e-09 | 195 | 199 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | TANC2 ARHGAP32 LRRC37A3 NAV2 KDM6A DOCK1 NEDD4L DYRK1A SIK3 SIPA1L1 LRBA | 1.62e-09 | 198 | 199 | 11 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-08 | 182 | 199 | 10 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.45e-08 | 189 | 199 | 10 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.52e-08 | 190 | 199 | 10 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.60e-08 | 191 | 199 | 10 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | TANC2 KMT2C ATP13A3 KDM6A RGPD8 SIK3 SIPA1L1 ANKRD11 LRBA ARMH4 | 1.77e-08 | 193 | 199 | 10 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | CENPC HNRNPH1 PRRC2C NFKBIB RANBP2 REL RUNX3 SYTL3 ANKRD11 ELF1 | 2.36e-08 | 199 | 199 | 10 | 945fbf5845403a8b22d04963f50ad69c414b6153 |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ARHGAP32 DENND2B NEGR1 TRPV2 DOCK10 DGKD ANKRD50 CDH19 PALLD | 7.71e-08 | 170 | 199 | 9 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-07 | 176 | 199 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-07 | 183 | 199 | 9 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-07 | 184 | 199 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-07 | 184 | 199 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-07 | 184 | 199 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-07 | 191 | 199 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-07 | 191 | 199 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-07 | 191 | 199 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.27e-07 | 193 | 199 | 9 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.27e-07 | 193 | 199 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 2.37e-07 | 194 | 199 | 9 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.48e-07 | 195 | 199 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.59e-07 | 196 | 199 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.82e-07 | 198 | 199 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | HNRNPH1 PRRC2C VPS13A GOLGB1 RGPD5 SYTL3 ANKRD11 LRBA SNRNP200 | 2.94e-07 | 199 | 199 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 200 | 199 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.15e-06 | 173 | 199 | 8 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | Healthy-multiplets|World / disease group, cell group and cell class | 1.62e-06 | 181 | 199 | 8 | f8dbac3cd500cc8d80853312b00d124c27b8fd85 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.68e-06 | 182 | 199 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 182 | 199 | 8 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.83e-06 | 184 | 199 | 8 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.83e-06 | 184 | 199 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-06 | 185 | 199 | 8 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.06e-06 | 187 | 199 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.23e-06 | 189 | 199 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.23e-06 | 189 | 199 | 8 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 2.32e-06 | 190 | 199 | 8 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.32e-06 | 190 | 199 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 2.32e-06 | 190 | 199 | 8 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-06 | 191 | 199 | 8 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-06 | 191 | 199 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.51e-06 | 192 | 199 | 8 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.51e-06 | 192 | 199 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.51e-06 | 192 | 199 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.61e-06 | 193 | 199 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.61e-06 | 193 | 199 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.61e-06 | 193 | 199 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-06 | 194 | 199 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-06 | 194 | 199 | 8 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.82e-06 | 195 | 199 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.04e-06 | 197 | 199 | 8 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-06 | 198 | 199 | 8 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 198 | 199 | 8 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 199 | 199 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.27e-06 | 199 | 199 | 8 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.27e-06 | 199 | 199 | 8 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 3.40e-06 | 200 | 199 | 8 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-06 | 200 | 199 | 8 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.40e-06 | 200 | 199 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-06 | 200 | 199 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.40e-06 | 200 | 199 | 8 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 200 | 199 | 8 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.92e-06 | 149 | 199 | 7 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.14e-06 | 150 | 199 | 7 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.53e-06 | 159 | 199 | 7 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.22e-06 | 164 | 199 | 7 | f88871d3b9307112eb7ced4c629f5704326ecae8 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.98e-06 | 166 | 199 | 7 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.04e-05 | 167 | 199 | 7 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.17e-05 | 170 | 199 | 7 | 403b6b749d70d845838dcda7daf99971b50792a2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 170 | 199 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 171 | 199 | 7 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 171 | 199 | 7 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-05 | 173 | 199 | 7 | f66aebceb3eb389bc5ff6c0b398d6f4e9959a14f | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.46e-05 | 176 | 199 | 7 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | droplet-Tongue-nan-3m-Myeloid|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 177 | 199 | 7 | b6c0ab701d9db3f19605b4d23f7e40adca3324e1 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 177 | 199 | 7 | e73e2b6a72630bb56ac2af1cdeedc8f0f828f390 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 177 | 199 | 7 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-05 | 177 | 199 | 7 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | droplet-Tongue-nan-3m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 177 | 199 | 7 | 34bd46704827c9db7053bbd0c671dd0b661b79b4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 178 | 199 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 178 | 199 | 7 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 178 | 199 | 7 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-05 | 179 | 199 | 7 | 33ed9270d257895ff3b40df2c1af878119c9f492 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.63e-05 | 179 | 199 | 7 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 181 | 199 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 181 | 199 | 7 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.75e-05 | 181 | 199 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 181 | 199 | 7 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 181 | 199 | 7 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 181 | 199 | 7 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 181 | 199 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 182 | 199 | 7 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 182 | 199 | 7 | 9465238ac806fce46dfe1a141e83893f23eb4afb | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.81e-05 | 182 | 199 | 7 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.88e-05 | 183 | 199 | 7 | 9dfb398b9995d562864fe688861a831ada0814cd | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.01e-05 | 124 | 199 | 6 | 9f169fa17be1842a6bd83778ff30465a740edd5f | |
| Drug | NSC708927 | 5.47e-08 | 13 | 196 | 5 | CID011970115 | |
| Drug | NSC366363 | 6.28e-07 | 3 | 196 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 6.28e-07 | 3 | 196 | 3 | CID004630710 | |
| Drug | tatsiensine | 6.28e-07 | 3 | 196 | 3 | CID000163526 | |
| Drug | delcosine | 6.28e-07 | 3 | 196 | 3 | CID000120726 | |
| Drug | Nsc642900 | 2.50e-06 | 4 | 196 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 2.50e-06 | 4 | 196 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 2.50e-06 | 4 | 196 | 3 | CID006439702 | |
| Drug | cloxacepride | 2.50e-06 | 4 | 196 | 3 | CID000068859 | |
| Drug | chloraniformethan | 2.50e-06 | 4 | 196 | 3 | CID000030331 | |
| Drug | Ti 233 | 2.50e-06 | 4 | 196 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 2.50e-06 | 4 | 196 | 3 | CID000080867 | |
| Drug | herbarumin III | 2.50e-06 | 4 | 196 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 2.50e-06 | 4 | 196 | 3 | CID000070583 | |
| Drug | KS-504e | 2.50e-06 | 4 | 196 | 3 | CID000129559 | |
| Drug | KS-504d | 2.50e-06 | 4 | 196 | 3 | CID000129557 | |
| Drug | Archanagelicine | 2.50e-06 | 4 | 196 | 3 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 2.50e-06 | 4 | 196 | 3 | CID000127194 | |
| Drug | Roylin | 2.50e-06 | 4 | 196 | 3 | CID000099924 | |
| Drug | KS-502 | 2.50e-06 | 4 | 196 | 3 | CID000129242 | |
| Drug | KS-501 | 2.50e-06 | 4 | 196 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 2.50e-06 | 4 | 196 | 3 | CID000637889 | |
| Drug | PS-990 | 2.50e-06 | 4 | 196 | 3 | CID000157810 | |
| Drug | SC-52458 | 3.58e-06 | 13 | 196 | 4 | CID000132706 | |
| Drug | phencyclidine | CHRNA7 CHRFAM7A CALM1 CALM2 CALM3 DYRK1A GRIN2A GRM1 SCPEP1 CDC25A | 4.01e-06 | 181 | 196 | 10 | CID000006468 |
| Drug | jujubogenin | 6.20e-06 | 5 | 196 | 3 | CID005318721 | |
| Drug | D 890 | 6.20e-06 | 5 | 196 | 3 | CID000134083 | |
| Drug | NSC-36360 | 6.20e-06 | 5 | 196 | 3 | CID000133340 | |
| Drug | alpha-CAO | 6.20e-06 | 5 | 196 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 6.20e-06 | 5 | 196 | 3 | CID005356151 | |
| Drug | 4H-1,4-benzothiazin-3-one | 6.20e-06 | 5 | 196 | 3 | CID000021396 | |
| Drug | Y-acid | 6.20e-06 | 5 | 196 | 3 | CID000007022 | |
| Drug | C16AA | 6.20e-06 | 5 | 196 | 3 | CID000488017 | |
| Drug | auranthine | 6.20e-06 | 5 | 196 | 3 | CID000130919 | |
| Drug | Ant-ATP | 6.20e-06 | 5 | 196 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 6.20e-06 | 5 | 196 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 6.20e-06 | 5 | 196 | 3 | CID005748474 | |
| Drug | Ac-dvda | 6.20e-06 | 5 | 196 | 3 | CID000146768 | |
| Drug | VUF 4576 | 6.20e-06 | 5 | 196 | 3 | CID000132784 | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | INCENP DGKG KCND3 NFKBIB AKAP6 HUS1 SIPA1L1 SMARCA1 IL1R1 PMFBP1 | 7.76e-06 | 195 | 196 | 10 | 2702_UP |
| Drug | AC1L1BXF | 8.81e-06 | 85 | 196 | 7 | CID000001650 | |
| Drug | C16:1n-7 | 1.16e-05 | 59 | 196 | 6 | CID000004668 | |
| Drug | AC1NSV6X | 1.23e-05 | 6 | 196 | 3 | CID005317173 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 1.23e-05 | 6 | 196 | 3 | CID000004307 | |
| Drug | 2,5-diketocamphane | 1.23e-05 | 6 | 196 | 3 | CID000020218 | |
| Drug | benziodarone | 1.23e-05 | 6 | 196 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 1.23e-05 | 6 | 196 | 3 | CID000633347 | |
| Drug | CI-922 | 1.23e-05 | 6 | 196 | 3 | CID000146938 | |
| Drug | caged PE | 1.23e-05 | 6 | 196 | 3 | CID000192405 | |
| Drug | propyl-methylenedioxyindene | 1.23e-05 | 6 | 196 | 3 | CID000145934 | |
| Drug | 1,3-diolein | 1.29e-05 | 90 | 196 | 7 | CID000033120 | |
| Drug | 8-azido cyclic AMP | 1.48e-05 | 18 | 196 | 4 | CID000115296 | |
| Drug | 1H-imidazole hydrochloride | 1.48e-05 | 18 | 196 | 4 | CID000518985 | |
| Drug | Clorgyline | 1.57e-05 | 168 | 196 | 9 | ctd:D003010 | |
| Drug | 1-(4-pyridyl)ethanol | 2.14e-05 | 7 | 196 | 3 | CID000090919 | |
| Drug | AC1L52O2 | 2.14e-05 | 7 | 196 | 3 | CID000196983 | |
| Drug | chloronitromethane | 2.14e-05 | 7 | 196 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 2.14e-05 | 7 | 196 | 3 | CID000159622 | |
| Drug | DyCl3 | 2.14e-05 | 7 | 196 | 3 | CID000066207 | |
| Drug | DAPpNP | 2.14e-05 | 7 | 196 | 3 | CID005492375 | |
| Drug | T 7188 | 2.14e-05 | 7 | 196 | 3 | CID000003311 | |
| Drug | MS-857 | 2.14e-05 | 7 | 196 | 3 | CID000129517 | |
| Drug | SQ 65442 | 2.14e-05 | 7 | 196 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 2.14e-05 | 7 | 196 | 3 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 2.14e-05 | 7 | 196 | 3 | CID000188375 | |
| Drug | TZC-5665 | 2.14e-05 | 7 | 196 | 3 | CID006449836 | |
| Drug | KHL-8430 | 2.14e-05 | 7 | 196 | 3 | CID000195711 | |
| Drug | CPU57 | 2.14e-05 | 7 | 196 | 3 | CID000195730 | |
| Drug | Drnflrfamide | 2.14e-05 | 7 | 196 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 2.14e-05 | 7 | 196 | 3 | CID003081980 | |
| Drug | asocainol | 2.14e-05 | 7 | 196 | 3 | CID000071161 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.38e-05 | 177 | 196 | 9 | 4652_DN | |
| Drug | 26 C | 2.84e-05 | 21 | 196 | 4 | CID005327159 | |
| Drug | proxyl nitroxide | 3.41e-05 | 8 | 196 | 3 | CID000076702 | |
| Drug | niludipine | 3.41e-05 | 8 | 196 | 3 | CID000089767 | |
| Drug | Ro 22-4839 | 3.41e-05 | 8 | 196 | 3 | CID000065839 | |
| Drug | HT-74 | 3.41e-05 | 8 | 196 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 3.41e-05 | 8 | 196 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 3.41e-05 | 8 | 196 | 3 | CID003085362 | |
| Drug | 3,7,8-trihydroxy-CPZ | 3.41e-05 | 8 | 196 | 3 | CID000467415 | |
| Drug | KS-504a | 3.41e-05 | 8 | 196 | 3 | CID000129577 | |
| Drug | NSP-805 | 3.41e-05 | 8 | 196 | 3 | CID000130349 | |
| Drug | escina | 3.71e-05 | 44 | 196 | 5 | CID006433489 | |
| Drug | phenothiazine | 3.71e-05 | 44 | 196 | 5 | CID000007108 | |
| Drug | promethazine | 4.62e-05 | 46 | 196 | 5 | CID000004927 | |
| Drug | Indoprofen [31842-01-0]; Up 200; 14.2uM; MCF7; HT_HG-U133A | SPTLC3 SPHK2 CLSTN3 KCND3 NFKBIB ACKR2 DYRK1A ANKRD55 DNAH17 | 4.88e-05 | 194 | 196 | 9 | 3345_UP |
| Drug | w66 | 5.08e-05 | 9 | 196 | 3 | CID006439460 | |
| Drug | 7,8-diOH-CPZ | 5.08e-05 | 9 | 196 | 3 | CID000159916 | |
| Drug | adamantanone | 5.08e-05 | 9 | 196 | 3 | CID000064151 | |
| Drug | picumast | 5.08e-05 | 9 | 196 | 3 | CID000431850 | |
| Drug | 5-exo-hydroxycamphor | 5.08e-05 | 9 | 196 | 3 | CID000440017 | |
| Drug | KS-505a | 5.08e-05 | 9 | 196 | 3 | CID003081782 | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; HL60; HT_HG-U133A | 5.50e-05 | 197 | 196 | 9 | 1863_DN | |
| Drug | rofecoxib; Down 200; 10uM; MCF7; HG-U133A | 5.72e-05 | 198 | 196 | 9 | 166_DN | |
| Drug | N-(4-aminobutyl)-2-naphthalenesulfonamide | 5.85e-05 | 25 | 196 | 4 | CID000004298 | |
| Drug | Kn 04 | 6.86e-05 | 26 | 196 | 4 | CID000131117 | |
| Drug | nocodazole | INCENP CENPC PTPRO MYO3B GOLGB1 RANBP2 CALM1 CALM2 CALM3 FNDC3A PPP5C RACGAP1 CDC25A NIN | 7.11e-05 | 477 | 196 | 14 | CID000004122 |
| Drug | Kr I | 7.21e-05 | 10 | 196 | 3 | CID005288675 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 7.21e-05 | 10 | 196 | 3 | CID000152034 | |
| Drug | norchlorpromazine | 7.21e-05 | 10 | 196 | 3 | CID000062875 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 3.05e-05 | 10 | 190 | 3 | C1631597 | |
| Disease | Malignant neoplasm of breast | XIRP1 STARD8 LRRC37A2 DGKG GIMAP1 LRRC37A MIA2 GOLGB1 AKAP6 COL11A1 UBR4 KIF16B SIK3 CLDN1 THBS1 ZNF436 SIPA1L1 PRKAA2 LRBA | 7.07e-05 | 1074 | 190 | 19 | C0006142 |
| Disease | lymphocyte count | SPHK2 ZBTB38 CEL MARK3 SANBR EXTL2 BNC1 ZNF469 USP4 KNL1 COL2A1 FLT3 PCDHGA11 PCDHGA7 DOCK10 NSD1 DGKD RUNX3 PPP5C DNAH17 PRKAA2 ANKRD11 ELF1 | 7.36e-05 | 1464 | 190 | 23 | EFO_0004587 |
| Disease | sphingomyelin measurement | SPTLC3 SPHK2 COL2A1 KIF16B SIK3 BTBD3 CELSR2 ANKRD11 RACGAP1 | 8.55e-05 | 278 | 190 | 9 | EFO_0010118 |
| Disease | glycerate measurement | 1.13e-04 | 15 | 190 | 3 | EFO_0021029 | |
| Disease | respiratory symptom measurement, COVID-19 | 1.18e-04 | 74 | 190 | 5 | EFO_0007939, MONDO_0100096 | |
| Disease | QRS duration | 1.44e-04 | 298 | 190 | 9 | EFO_0005055 | |
| Disease | Colorectal Carcinoma | CLSTN3 STARD8 KMT2C FAT1 KCND3 PTPRS VPS13A KDM6A AKAP6 GRIN2A GRM1 ABCG1 SDCBP2 SNRNP200 | 1.97e-04 | 702 | 190 | 14 | C0009402 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.02e-04 | 45 | 190 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | melanoma | 2.17e-04 | 248 | 190 | 8 | C0025202 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.81e-04 | 49 | 190 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | GABRR1 CHRNA7 PIK3C3 STARD9 DLG4 CHRFAM7A CALM2 GRIN2A TLL2 ATP1A2 CSMD1 | 2.86e-04 | 477 | 190 | 11 | C0005586 |
| Disease | Neurodevelopmental Disorders | 3.45e-04 | 93 | 190 | 5 | C1535926 | |
| Disease | Hepatitis | 3.70e-04 | 22 | 190 | 3 | HP_0012115 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3.81e-04 | 53 | 190 | 4 | C1961099 | |
| Disease | lobe attachment | 4.06e-04 | 207 | 190 | 7 | EFO_0007667 | |
| Disease | Stickler syndrome | 4.07e-04 | 5 | 190 | 2 | cv:C0265253 | |
| Disease | Stickler syndrome, type 1 | 4.07e-04 | 5 | 190 | 2 | C2020284 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 4.07e-04 | 5 | 190 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | comparative body size at age 10, self-reported | LRRC37A2 SANBR PIK3C3 NEGR1 CAMTA1 AKAP6 FLT3 LRRC25 CSMD1 CDC25A | 4.21e-04 | 420 | 190 | 10 | EFO_0009819 |
| Disease | alcohol consumption measurement | ZBTB38 MARK3 CHDH TENM2 CHRNA7 HNRNPH1 NEGR1 CAMTA1 CHRFAM7A AKAP6 DOCK1 BTBD3 LRRC25 ANKRD11 AKAP11 CSMD1 ST18 CDH4 ARMH4 | 4.46e-04 | 1242 | 190 | 19 | EFO_0007878 |
| Disease | Weight Gain | 5.28e-04 | 102 | 190 | 5 | C0043094 | |
| Disease | cleft lip | 5.36e-04 | 284 | 190 | 8 | EFO_0003959 | |
| Disease | irritable bowel syndrome symptom measurement | 5.39e-04 | 58 | 190 | 4 | EFO_0021536 | |
| Disease | adverse effect, response to xenobiotic stimulus | 5.75e-04 | 59 | 190 | 4 | EFO_0009658, GO_0009410 | |
| Disease | lymphocyte:monocyte ratio | 5.87e-04 | 288 | 190 | 8 | EFO_0600088 | |
| Disease | cognitive disorder (implicated_via_orthology) | 6.08e-04 | 6 | 190 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 6.08e-04 | 6 | 190 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | Epilepsy | 7.14e-04 | 109 | 190 | 5 | C0014544 | |
| Disease | coronary artery disease | CEL KIF1A MARK3 DENND2B PTPRO BICC1 COL2A1 FAT4 ARHGEF12 ANKRD50 SIPA1 ANKRD55 TMEM106B CELSR2 TMEM132D CDC25A PALLD PMFBP1 | 7.47e-04 | 1194 | 190 | 18 | EFO_0001645 |
| Disease | Phencyclidine-Related Disorders | 8.48e-04 | 7 | 190 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 8.48e-04 | 7 | 190 | 2 | C0031391 | |
| Disease | cortical thickness | MARK3 FAM178B TENM2 BNC1 ZNF469 NAV2 CAMTA1 AKAP6 COL11A1 ARHGEF12 HIF1AN TMEM106B THBS1 ABCG1 UTP4 ST18 MYO16 | 9.10e-04 | 1113 | 190 | 17 | EFO_0004840 |
| Disease | mean platelet volume | ARHGAP32 ZBTB38 STARD8 DENND2B ANKRD28 ATP13A3 CAMTA1 COL6A6 PCDHGA11 PCDHGA7 KIF16B DYRK1A DOCK10 SIK3 ANKRD11 NIN | 9.76e-04 | 1020 | 190 | 16 | EFO_0004584 |
| Disease | advanced glycation end-product measurement, type 2 diabetes mellitus | 1.13e-03 | 8 | 190 | 2 | EFO_0007819, MONDO_0005148 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | PTPRO NEGR1 USP4 AKAP6 COL11A1 GRIN2A FAM193A KDM4A PPP1R16A | 1.17e-03 | 398 | 190 | 9 | EFO_0003756, EFO_0003888, EFO_0004337 |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.35e-03 | 74 | 190 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Alzheimer's disease (is_marker_for) | 1.44e-03 | 257 | 190 | 7 | DOID:10652 (is_marker_for) | |
| Disease | sensory perception of sound | 1.44e-03 | 9 | 190 | 2 | GO_0007605 | |
| Disease | thoracic aortic calcification measurement | 1.44e-03 | 9 | 190 | 2 | EFO_0010273 | |
| Disease | PR interval | MARK3 ZNF469 FAT1 KCND3 NAV2 CAMTA1 AKAP6 COL13A1 THBS1 SIPA1L1 | 1.46e-03 | 495 | 190 | 10 | EFO_0004462 |
| Disease | coronary aneurysm | 1.48e-03 | 35 | 190 | 3 | EFO_1000881 | |
| Disease | open-angle glaucoma | 1.53e-03 | 191 | 190 | 6 | EFO_0004190 | |
| Disease | Cannabis Abuse | 1.79e-03 | 10 | 190 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 1.79e-03 | 10 | 190 | 2 | C0236735 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 1.79e-03 | 10 | 190 | 2 | EFO_0021020 | |
| Disease | Hashish Abuse | 1.79e-03 | 10 | 190 | 2 | C0018614 | |
| Disease | macrophage inflammatory protein 1b measurement | 1.91e-03 | 136 | 190 | 5 | EFO_0008219 | |
| Disease | Epilepsy, Cryptogenic | 1.97e-03 | 82 | 190 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.97e-03 | 82 | 190 | 4 | C0751111 | |
| Disease | Aura | 1.97e-03 | 82 | 190 | 4 | C0236018 | |
| Disease | psoriasis | 2.03e-03 | 273 | 190 | 7 | EFO_0000676 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.11e-03 | 139 | 190 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | neutrophil percentage of leukocytes | SPHK2 ZBTB38 CEL MARK3 EXTL2 HNRNPH1 COL2A1 FLT3 LRRC25 ELF1 AKAP11 | 2.11e-03 | 610 | 190 | 11 | EFO_0007990 |
| Disease | primary angle closure glaucoma | 2.18e-03 | 11 | 190 | 2 | EFO_1001506 | |
| Disease | interleukin-22 receptor subunit alpha-2 measurement | 2.18e-03 | 11 | 190 | 2 | EFO_0020500 | |
| Disease | optic disc size measurement | 2.19e-03 | 205 | 190 | 6 | EFO_0004832 | |
| Disease | Crohn's disease | ZBTB38 RUNX3 ANKRD55 TMEM106B CELSR3 PPP5C ELF1 AKAP11 IL1R1 | 2.34e-03 | 441 | 190 | 9 | EFO_0000384 |
| Disease | urate measurement, bone density | SPTLC3 MYL1 TENM2 SLC23A2 AKAP6 PARG DGKD ASS1 ANKRD11 CDH4 MYO16 | 2.36e-03 | 619 | 190 | 11 | EFO_0003923, EFO_0004531 |
| Disease | clostridium difficile infection | 2.45e-03 | 144 | 190 | 5 | EFO_0009130 | |
| Disease | cesarean section, intelligence | 2.61e-03 | 12 | 190 | 2 | EFO_0004337, EFO_0009636 | |
| Disease | nervous system disease (implicated_via_orthology) | 2.61e-03 | 12 | 190 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.61e-03 | 12 | 190 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | outer ear morphology trait | 2.61e-03 | 12 | 190 | 2 | EFO_0007664 | |
| Disease | Memory Loss | 2.68e-03 | 43 | 190 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 2.68e-03 | 43 | 190 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 2.68e-03 | 43 | 190 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 2.68e-03 | 43 | 190 | 3 | C0751293 | |
| Disease | triglycerides in large LDL measurement | 2.68e-03 | 43 | 190 | 3 | EFO_0022319 | |
| Disease | Memory Disorders | 2.68e-03 | 43 | 190 | 3 | C0025261 | |
| Disease | obsolete_red blood cell distribution width | SPHK2 CEL MARK3 LRRC37A2 DENND2B PRRC2C VPS13A USP4 SLC23A2 WNK3 KNL1 FLT3 SIK3 SIPA1 GRSF1 LRRC25 MYO16 ARMH4 | 2.82e-03 | 1347 | 190 | 18 | EFO_0005192 |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 2.84e-03 | 216 | 190 | 6 | EFO_0007925, EFO_0007927 | |
| Disease | Memory impairment | 2.87e-03 | 44 | 190 | 3 | C0233794 | |
| Disease | ankylosing spondylitis | 2.88e-03 | 91 | 190 | 4 | EFO_0003898 | |
| Disease | adipose tissue measurement | 3.06e-03 | 45 | 190 | 3 | EFO_0004764 | |
| Disease | illegal drug consumption | 3.07e-03 | 13 | 190 | 2 | EFO_0005431 | |
| Disease | myeloid white cell count | SCFD2 SPHK2 CEL DGKG EXTL2 DENND2B ACKR2 FLT3 COL11A1 DYRK1A ARHGEF12 SIK3 LRRC25 AKAP11 | 3.12e-03 | 937 | 190 | 14 | EFO_0007988 |
| Disease | body surface area | ZBTB38 KIF1A DGKG MAP3K3 HAGHL NSD1 ARHGEF12 HIF1AN LMO1 ASS1 ANKRD11 | 3.15e-03 | 643 | 190 | 11 | EFO_0022196 |
| Disease | glaucoma | 3.28e-03 | 154 | 190 | 5 | MONDO_0005041 | |
| Disease | Squamous cell carcinoma of esophagus | 3.36e-03 | 95 | 190 | 4 | C0279626 | |
| Disease | prostate cancer (is_marker_for) | 3.46e-03 | 156 | 190 | 5 | DOID:10283 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 3.46e-03 | 156 | 190 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | heart rate | 3.47e-03 | 225 | 190 | 6 | EFO_0004326 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 3.49e-03 | 301 | 190 | 7 | DOID:684 (is_marker_for) | |
| Disease | triacylglycerol 46:2 measurement | 3.57e-03 | 14 | 190 | 2 | EFO_0010402 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 3.57e-03 | 14 | 190 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | platelet crit | SCFD2 DENND2B GAPDHS COL2A1 ZNF487 FLT3 KIF16B DOCK10 ARHGEF12 DGKD THBS1 ANKRD19P CSTF1 ELF1 | 3.60e-03 | 952 | 190 | 14 | EFO_0007985 |
| Disease | neutrophil count | SCFD2 SPHK2 CEL DGKG DENND2B KCND3 ACKR2 FLT3 COL11A1 DYRK1A NSD1 ARHGEF12 SIK3 RUNX3 LRRC25 ANKRD11 AKAP11 LRBA | 3.69e-03 | 1382 | 190 | 18 | EFO_0004833 |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 3.70e-03 | 228 | 190 | 6 | EFO_0003948, MONDO_0004975 | |
| Disease | reaction time measurement | LRRC37A2 TENM2 PTPRO NAV2 CAMTA1 AKAP6 GRIN2A CDH19 ANKRD19P CSMD1 PPP1R16A | 3.75e-03 | 658 | 190 | 11 | EFO_0008393 |
| Disease | neuroimaging measurement | SCFD2 MARK3 PSMD1 ZNF469 PRRC2C NAV2 CAMTA1 COL2A1 COL11A1 HAGHL ARHGEF12 HIF1AN THBS1 UTP4 MYO16 | 4.03e-03 | 1069 | 190 | 15 | EFO_0004346 |
| Disease | Adenoid Cystic Carcinoma | 4.04e-03 | 100 | 190 | 4 | C0010606 | |
| Disease | osteoarthritis (implicated_via_orthology) | 4.10e-03 | 15 | 190 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Tourette syndrome | 4.12e-03 | 50 | 190 | 3 | EFO_0004895 | |
| Disease | phospholipids in very small VLDL measurement | 4.36e-03 | 51 | 190 | 3 | EFO_0022300 | |
| Disease | Spondyloepiphyseal Dysplasia | 4.66e-03 | 16 | 190 | 2 | C0038015 | |
| Disease | Diabetic Angiopathies | 4.66e-03 | 16 | 190 | 2 | C0011875 | |
| Disease | Romano-Ward Syndrome | 4.66e-03 | 16 | 190 | 2 | C0035828 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 4.66e-03 | 16 | 190 | 2 | C3541456 | |
| Disease | Microangiopathy, Diabetic | 4.66e-03 | 16 | 190 | 2 | C0025945 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GMNDLGERQSENYPN | 361 | O00590 | |
| SYRDSAENEECGQPM | 1376 | Q9Y6Y1 | |
| NSYAGLACVEEPNDM | 46 | P32519 | |
| METQQVQEKYADSPG | 151 | P32519 | |
| YSEGDAVSQPQMALE | 146 | Q9HB65 | |
| NISGQDMVDAINECY | 216 | Q9UJ72 | |
| SEVYNMPLESQGDEN | 2561 | Q6UB99 | |
| AEYQGIVMENDNTVL | 31 | Q9BQT9 | |
| ENSNGQASFENPMYD | 3526 | Q96PZ7 | |
| IDGDGQVNYEEFVQM | 131 | P0DP25 | |
| DMENIYQTHAEGDIG | 1666 | Q68DQ2 | |
| MEVASGEYGDQNSRL | 326 | P45844 | |
| GPAVGIYNDNINTEM | 701 | Q9H5V8 | |
| QGQEDEMEIYGYNLS | 11 | Q9H7F0 | |
| EVMNSLYSGDPQDQL | 306 | P54646 | |
| GNMDLLEGATYQVPD | 671 | Q86TY3 | |
| GQLDYEIVNGNMENS | 2701 | Q6V0I7 | |
| PEQYMLEQGHDQSQD | 261 | Q01954 | |
| LDLGVDMNEPNAYGN | 226 | O15084 | |
| QVYSEDMALNIGSEP | 2236 | Q8IYW2 | |
| NELSYFGQEGMTEVQ | 476 | Q9Y2F9 | |
| EGGNSELIMDQYANR | 1356 | Q9UKA4 | |
| MAQEDAQRLYQAGEG | 341 | P20073 | |
| ENQLTMAEYFLENGA | 956 | Q9ULJ7 | |
| VDLTMVYQAASNGDV | 26 | Q3KP44 | |
| TDPDEGTNAQIMYQI | 946 | Q9HCU4 | |
| DFGQNGAMDVNLTVY | 691 | Q13627 | |
| NAADIDYIAGTNNMD | 326 | P19835 | |
| QYLEELPDTEQSGMN | 1106 | P78524 | |
| MAAQGEPGYLAAQSD | 1 | Q9H694 | |
| IDGDGQVNYEEFVQM | 131 | P0DP24 | |
| LSNYDDTEVVANMNG | 311 | P78312 | |
| YEQMNGPVAGASRQE | 26 | P29692 | |
| NEELVSMNVQGDYEP | 371 | P00966 | |
| SMNVQGDYEPTDATG | 376 | P00966 | |
| QMQEADISGYIPNGE | 181 | P36544 | |
| SMSDNGAQIYELVAQ | 1101 | Q9NZN5 | |
| TQQAGYPLTEDMNGF | 206 | Q8NE62 | |
| LGQALLDSMDQEYAG | 11 | Q9H560 | |
| YGDDNLAPNTANVQM | 1361 | P02458 | |
| LVQNYGDVEELMDAG | 191 | Q96L93 | |
| MGTNYQLGTGQDEDA | 371 | P18754 | |
| QGYDINSQGEESMGN | 476 | Q9Y5P3 | |
| LNSVMQELEDYSEGG | 746 | P49792 | |
| MINVEYLNGSADGSE | 81 | Q96L73 | |
| ETAFYEMEVQAQDGP | 311 | Q9Y5G6 | |
| IVDYNENMGAVDSAD | 421 | Q96DM1 | |
| LNSVMQELEDYSEGG | 746 | Q99666 | |
| LNSVMQELEDYSEGG | 746 | O14715 | |
| EGSAQQMYQSLAELG | 146 | Q6PII5 | |
| AEIYNQCEEQGMESP | 721 | P57740 | |
| NATDPDEGINGEVMY | 266 | Q9Y5H2 | |
| GEAYVQFEEPEMANQ | 291 | Q12849 | |
| EEEMEVLQYTAGGNV | 226 | Q7Z3Y9 | |
| AADNMQAIYVALGEA | 16 | Q5SQ64 | |
| ILCQMDYEEGQLNGT | 136 | P25800 | |
| ADSGTNGQVMYSLDQ | 2836 | Q14517 | |
| YIGLVMTNNEDVSGA | 271 | Q9UK17 | |
| TNMPEGTISENTNYN | 1406 | O60309 | |
| AELTTDYNNEMEVEG | 536 | Q8NEZ4 | |
| TNMPEGTISENTNYN | 1406 | A6NM11 | |
| TNMPEGTISENTNYN | 1406 | A6NMS7 | |
| IYDISNDMTVNEGTN | 141 | Q7Z3B1 | |
| NPGYSNSELQINMTD | 481 | Q8TAT5 | |
| KINPDNYGMDLNSDD | 816 | Q9NQS7 | |
| MEGNVTPAHYDEQQN | 191 | Q9NWT6 | |
| EGVTMETAYSPGNQN | 821 | Q9Y6X6 | |
| DAYSQMQLVQSGAEV | 16 | A0A0A0MS14 | |
| NLQSLGQAPMDEEEY | 286 | Q8N386 | |
| MDLGTLYESCNQPQD | 356 | O15550 | |
| PVNMDNLEKETNSGY | 266 | Q9UBQ6 | |
| GSNDEEMSYDNNPFI | 1736 | P12107 | |
| SAGTEYMDLQNDLGQ | 81 | Q15653 | |
| GQSSMSGYDQVLQEN | 426 | P55795 | |
| NQVSYGEMVGCDNQD | 366 | Q9NXR8 | |
| TYEGTIEENGQGMLQ | 721 | Q86W56 | |
| HPIQMYQVEFEDGSQ | 981 | O75164 | |
| NYNLGVMDDGTVVSD | 2376 | P50851 | |
| ENQTQNAMDVTTGYG | 366 | Q8NG31 | |
| TVTYLTLQGNDQDDM | 756 | Q9NX02 | |
| LMAGQEDSNGCINYE | 171 | P05976 | |
| DVVSQALDGYNGTIM | 76 | Q9HAQ2 | |
| GQSSMSGYDQVLQEN | 426 | P31943 | |
| SQYDNMTPAVQDDLG | 1771 | A7KAX9 | |
| QMQEADISGYIPNGE | 91 | Q494W8 | |
| EGGDETSYFIVMVNN | 1736 | Q96RW7 | |
| LQESYLDVGGSEANM | 191 | Q49AM1 | |
| KQEEEGQQQEEEGMY | 391 | Q86Y26 | |
| LVSMNEEEGADYINA | 981 | Q16827 | |
| QPIEGIMGSDYINAN | 1436 | Q13332 | |
| DEVQYGDVPVENGMA | 986 | Q8WX93 | |
| TLDDDGNYTIMAANP | 1066 | Q8WX93 | |
| PYEAVVSQMDQEQGS | 196 | Q15884 | |
| QLADAEEAMYQNVDG | 946 | P36888 | |
| EEVENGDQVPYSIMN | 566 | P49619 | |
| YEQMNGPVAGASLQE | 26 | Q658K8 | |
| LAYGIQAAMEDEPSN | 111 | P50993 | |
| MATDEENVYGLEENA | 6 | Q8WWP7 | |
| IGEQMVQNAEDVYEA | 416 | O43464 | |
| MLDGNYSDGEVNDLD | 396 | P24046 | |
| QLSDGGEYTVVAMQD | 481 | Q8N9C0 | |
| DSGMQDTPYNENILV | 1796 | Q96BY6 | |
| GSVADYGNLMENQDL | 1806 | Q14185 | |
| NTVDVENGASMAGYA | 66 | Q96EE4 | |
| AGDNIVTAQAMYEGL | 36 | O95832 | |
| ILYDAQMAASEEGNI | 561 | Q9UFH2 | |
| NNYLMSGKNDVDDEE | 691 | Q03188 | |
| MDVPENNQHGYEAGS | 771 | Q86TI2 | |
| INKYVVEMAEGSNGN | 596 | Q9Y2H6 | |
| MNPDGYEKSQEGDSI | 606 | O75976 | |
| ATDMEGNLNYGLSNT | 361 | P55283 | |
| DEAEIYSLTNMEGNI | 16 | A4D0Y5 | |
| DVDMLCDTLYQGGNQ | 506 | Q68CZ6 | |
| PGLNEIMANSLDYNE | 146 | Q9BYF1 | |
| ELQVNGTEGEMEYEE | 51 | P78352 | |
| SVALYDAIMNAGQEE | 691 | Q9UI17 | |
| VGMGYSQEEIQESLS | 336 | P27448 | |
| MSNQYQEEGCSERPE | 1 | Q96QS3 | |
| EEATQMDQFGQAAGV | 976 | Q16760 | |
| GTYLSESQVNEIEMQ | 231 | Q8TB03 | |
| IDGDGQVNYEEFVQM | 131 | P0DP23 | |
| EYNVNDDSMKLGGNN | 331 | Q14527 | |
| GEMVDYNGNINEALQ | 441 | Q5TAT6 | |
| MESYELVVEASDQGQ | 506 | Q9NYQ7 | |
| LGMENDDTAVQYAIG | 56 | Q05048 | |
| GNESLEENYVQDSKM | 396 | Q13255 | |
| VNENDYNPGSMNIVS | 206 | O14556 | |
| GSSEEQIAMYNALVQ | 466 | P14778 | |
| GTIMAYDNDIGENAE | 276 | Q9H159 | |
| LNVDSNEQGSYVVAM | 336 | Q16531 | |
| QEVVANLQYDDGSGM | 1106 | Q16531 | |
| LQNDQAMGGSTYTAE | 876 | A6NMZ7 | |
| EMGYNCFSLENQETP | 151 | A0A1W2PPM1 | |
| VTSYNDIQDLMDSGN | 186 | Q12756 | |
| STNGENMGLAVQYLD | 316 | Q99759 | |
| PLHADMDTNGYETDN | 436 | Q8N108 | |
| TVTMDQLQGLGSDYE | 46 | P30304 | |
| LEMNSESENGAYLDN | 901 | Q96PC5 | |
| NTIYEIQDNTGSMDV | 336 | P41218 | |
| LYEEEMGNHNENTGE | 141 | Q8TBY8 | |
| EKPDSYMEGASESQQ | 711 | Q92834 | |
| VVTVMAGNDENYSAE | 106 | Q13761 | |
| TEMGNFDNANVTGEI | 296 | Q4VX76 | |
| DAYDGVTSENMRNGL | 16 | Q9NUM4 | |
| SAGLNGEIMEYDLQA | 76 | Q969X6 | |
| MSYEESQDLQLCVNG | 301 | Q6NW40 | |
| AQPSQGTEQEKMDYA | 556 | Q8WZA2 | |
| EEMGNPDASYNLGVL | 791 | Q68CR1 | |
| SVQMYAQAALDGDSQ | 971 | Q68CR1 | |
| SLYENGVNGILADEM | 196 | P28370 | |
| NSADGASYEVMQIDV | 371 | Q14C87 | |
| CEQYGLQNVDGEMLE | 211 | Q8N4C6 | |
| AEMIIEQNTDGVNFY | 256 | Q9HB40 | |
| YNGQLDLIVDTMGQE | 366 | Q9HB40 | |
| TDNMNQIYGFEGEVK | 306 | P53041 | |
| QAQPGAYTDENLMGL | 436 | Q8IXR5 | |
| EFQMEGVSAENNEIY | 66 | O60921 | |
| ENGPNGISAEVMDTY | 711 | Q8NEB9 | |
| SMDGAQNQDDGYLAL | 1191 | Q8IVL1 | |
| GAQMEVDYTEQLNFS | 321 | Q9Y520 | |
| ANLLAVNTDGNMPYD | 161 | Q96I34 | |
| AQAIEDMVGYAQETQ | 526 | Q99460 | |
| GQSTEEEMYNNESAG | 621 | O43166 | |
| SDDAYVQLDNLPGMS | 1221 | Q9Y2K2 | |
| SLMGSQQFQDGENEE | 1256 | Q9Y2K2 | |
| RAGQGSEEEMYNNQE | 341 | Q96FS4 | |
| SEEEMYNNQEAGPAF | 346 | Q96FS4 | |
| QPGDQYSMEVQDENQ | 106 | Q9HCD6 | |
| STQNLELGLMTYDGN | 1671 | Q9NT68 | |
| AAAAEMEGQQPVFEQ | 121 | Q8WU76 | |
| AIDIYEQVGTNAMDS | 181 | P54920 | |
| QEMGFIIYGNENASV | 446 | Q9NUV7 | |
| EPSYSEQADSLQGMQ | 1311 | Q9P2P6 | |
| VDNQYNSLMAAGESP | 66 | Q6NSI8 | |
| EDNSIAAMYQAVGEL | 451 | Q9H0H5 | |
| QMNETSPDNVCYEGQ | 621 | Q92502 | |
| ENYMGLSLSSQEVQE | 51 | Q9H190 | |
| MGPISEQNFEAYVNT | 1001 | O60284 | |
| NKDPYVADMENGNIE | 1886 | Q13023 | |
| VDYDEGTDVFQQLNM | 131 | Q13454 | |
| VYNVDQRDTDMDGVG | 816 | P07996 | |
| GQAMDQDGPSEMQEY | 91 | Q14592 | |
| SGIAAENMVVADVYN | 526 | Q13107 | |
| LECMENNLPYDDNGT | 26 | P0CB48 | |
| DVMQENYGNVVSLDF | 41 | Q9C0F3 | |
| GSAYTDMNVVDIQVN | 1136 | Q96RL7 | |
| QAQIDAEMDSTPVGY | 246 | Q96BR9 | |
| VDGEQVEYGPLQAQM | 621 | Q9NRA0 | |
| SGEQDNEDTELMAIY | 46 | Q9UGH3 | |
| QPMEGQEDEGNGAQY | 576 | Q9Y5S1 | |
| GDMNKDAGQIQSPNY | 466 | Q9Y6L7 | |
| QYSGIGSMQNEQLSD | 596 | Q04864 | |
| AIEIYEQVGANTMDN | 181 | Q9H115 | |
| ALNSNAEELDVMYGG | 451 | O15195 | |
| EALNGMEYQSDNPEI | 846 | Q96JG9 | |
| KEIQNMDDNIDETYG | 186 | O75643 | |
| MDDNIDETYGVNVQF | 191 | O75643 | |
| NDVSGEATAQEMYLP | 2136 | Q5VWN6 | |
| ENSQMNESAPGTYVV | 591 | Q8NAP3 | |
| QLRYASQEPEGAMQG | 606 | P52746 | |
| YTQLMEEASSAQQGP | 2071 | Q5T4S7 | |
| QYEEVDQFGNTVLMS | 1771 | Q702N8 | |
| DVMVQNYENLVSVAG | 31 | Q2M3W8 | |
| GYTEERNPMNALNVG | 251 | B1APH4 | |
| VQQPAMDAEFISQEG | 1046 | Q9BYP7 | |
| QNYDEMSPAGQISKE | 961 | Q14789 | |
| ALEQMEYQNEGIDAV | 756 | Q8WXR4 | |
| SDDDGNYTIMAANPQ | 1011 | Q86TC9 | |
| YDIDEDQMLQETGNP | 1246 | Q12879 | |
| AYMPKNGGQDEENSD | 151 | Q96PU5 |